Adverse effects, not elsewhere classified

ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T78 Cause of death: ICD-10 — T78 2 out of 7 registries used, show all original rules.	9460
4. Check minimum number of events None	9460
5. Include endpoints None	9460
6. Filter based on genotype QC (FinnGen only)	9031

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus adversi non alibi classificati

NAME	ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T78
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T78
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Adverse effects, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9031	6428	2603
Unadjusted period prevalence (%)	1.97	2.28	1.19
Median age at first event (years)	47.69	45.14	53.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9460: Matched controls
94600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06AE09

ATC

levocetirizine; oral

2.7

318.5

2111

9048

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

317.8

2375

10801

H02AB06

ATC

prednisolone; systemic

4.4

307.7

6456

31181

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.8

307.7

2326

5058

X59

ICD-10 Finland

Exposure to unspecified factor

4.0

307.7

3166

10582

C01CA24

ATC

epinephrine; parenteral

25.5

307.7

4149

2816

L50.0

ICD-10 Finland

Allergic urticaria

7.8

307.7

797

1106

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

512.9

307.7

1922

L50.8

ICD-10 Finland

Other urticaria

9.0

307.7

566

666

T78.3

ICD-10 Finland

Angioneurotic oedema

284.7

307.7

2122

R06AX27

ATC

desloratadine; oral

2.6

307.7

4035

21224

L50.9

ICD-10 Finland

Urticaria, unspecified

6.5

307.7

1033

1753

W84

ICD-10 Finland

Unspecified threat to breathing

98.0

307.7

276

T78.4

ICD-10 Finland

Allergy, unspecified

162.0

307.7

6433

1225

X58

ICD-10 Finland

Exposure to other specified factors

3.1

307.7

2094

7871

A92

ICPC

Allergy/allergic reaction NOS

5.8

307.7

807

1507

XQ800

NOMESCO Finland

Prick test

8.0

307.7

2481

4017

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

49.4

307.7

756

166

X57

ICD-10 Finland

Unspecified privation

10.6

307.7

713

725

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

160.2

307.7

173

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

6.8

307.7

905

1439

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.5

307.7

1522

4944

R06AE07

ATC

cetirizine; oral

3.4

307.7

6070

32875

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

562.4

307.7

327

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

24.6

307.7

1242

577

R03AC02

ATC

salbutamol; inhalant

2.3

304.3

6058

41600

H02AB07

ATC

prednisone; oral

2.9

303.0

1702

6676

R03DC03

ATC

montelukast; oral

2.6

296.9

2241

10200

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.9

269.2

376

494

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.8

267.5

631

1385

R06.0

ICD-10 Finland

Dyspnoea

2.2

247.6

2736

14570

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.4

244.4

2245

11056

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

243.5

4169

26206

Z51.6

ICD-10 Finland

Desensitization to allergens

7.3

234.7

350

495

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

24.9

233.1

164

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

228.1

4185

26781

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

3.1

222.5

1030

3592

N02AX02

ATC

tramadol; systemic, rectal

2.0

215.3

4067

26139

R06AX22

ATC

ebastine; oral

2.3

211.1

2096

10588

L27.2

ICD-10 Finland

Dermatitis due to ingested food

7.7

208.0

294

391

R03BA02

ATC

budesonide; inhalant

2.2

203.3

2087

10668

Z3231

NOMESCO Finland

Registered nurse

2.1

203.3

2834

16293

J01FF01

ATC

clindamycin; systemic

2.0

197.8

2816

16283

X27

ICD-10 Finland

Contact with other specified venomous animals

37.4

197.4

122

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

6.2

187.2

326

542

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

8.6

183.9

237

282

A02BC02

ATC

pantoprazole; systemic

1.9

182.0

6302

48331

R06AX13

ATC

loratadine; oral

2.2

181.8

1881

9598

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

180.4

2842

16931

R60.0

ICD-10 Finland

Localized oedema

2.5

179.0

1258

5425

Y96.9

ICD-10 Finland

Unspecified type of accident

5.9

178.8

327

570

R51.80

ICD-10 Finland

Headache

2.2

177.5

1950

10177

S01GX01

ATC

cromoglicic acid; ophthalmic

2.0

176.9

2404

13582

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

176.6

2711

15985

XQ802

NOMESCO Finland

Epicutan test

3.5

174.9

652

1985

XQ820

NOMESCO Finland

Exposure to medicinal substance

14.0

174.8

161

117

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

7.6

173.5

248

334

M79.6

ICD-10 Finland

Pain in limb

1.8

166.2

4171

28651

R03BA05

ATC

fluticasone; inhalant

2.1

165.4

2072

11328

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

162.0

2541

15019

H02AB04

ATC

methylprednisolone; systemic

2.2

161.9

1519

7418

L50.3

ICD-10 Finland

Dermatographic urticaria

5.1

160.7

345

696

N03AX16

ATC

[U] pregabalin

2.0

159.0

2243

12772

L20.0

ICD-10 Finland

Besnier prurigo

2.5

158.5

1118

4815

R03AC03

ATC

terbutaline; inhalant

2.2

152.1

1563

7901

E0000UV, ,

ATC

1.8

150.3

4247

29924

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

147.2

1939

10741

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

146.1

1514

7669

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

145.0

1420

7032

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

142.9

1897

10524

R02

ICPC

Shortness of breath/dyspnoea

2.2

140.5

1334

6518

XQ801

NOMESCO Finland

Intracutantest

10.2

138.0

156

R01AD09

ATC

mometasone; nasal

1.7

137.7

4649

34132

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

21.2

137.6

103

J45

ICD-10 Finland

Asthma

2.3

137.5

1198

5647

R01AD08

ATC

fluticasone; nasal

1.8

133.6

2968

19347

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

133.3

1405

7144

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

132.9

2752

17568

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

132.6

2031

11795

J46

ICD-10 Finland

Status asthmaticus

3.9

132.3

400

1055

J01AA02

ATC

doxycycline; systemic

1.8

131.5

7032

58246

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

129.5

5395

41617

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.0

125.5

570

1948

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

123.8

2203

13384

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

123.3

827

3462

AA1AD

NOMESCO Finland

CT of head and brain

1.8

121.9

2197

13391

J01MA12

ATC

levofloxacin; systemic

2.0

120.2

1601

8838

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

119.8

558

1934

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

119.3

593

2131

J01FA10

ATC

azithromycin; systemic

1.7

119.2

5850

46620

J01MA02

ATC

ciprofloxacin; systemic

1.7

117.8

3316

22905

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

13.8

117.6

109

A02BC05

ATC

esomeprazole; systemic

1.7

117.5

3674

26079

L50.1

ICD-10 Finland

Idiopathic urticaria

7.3

117.4

173

241

J01DB01

ATC

cefalexin; oral

1.9

116.4

7872

68322

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

116.2

1813

10539

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

116.1

2130

13026

R42

ICD-10 Finland

Dizziness and giddiness

1.8

115.3

2039

12326

M54.5

ICD-10 Finland

Low back pain

1.7

114.5

3503

24681

J01FA06

ATC

roxithromycin; oral

1.7

114.4

3624

25760

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

113.7

855

3767

R96

ICPC

Asthma

2.2

113.3

1023

4872

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

113.1

4054

29704

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

7.0

112.7

172

249

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

27.4

111.8

WQ000

NOMESCO Finland

Hyposensibilisation

7.6

110.4

156

207

D07AB08

ATC

desonide; topical

2.1

109.7

1153

5827

XQ899

NOMESCO Finland

Other assessment of skin

10.2

109.4

123

122

N02BE01

ATC

paracetamol; systemic, rectal

2.0

109.4

8240

72980

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

106.2

2032

12540

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

106.1

1939

11802

G44.2

ICD-10 Finland

Tension-type headache

1.9

105.7

1504

8458

Z3226

NOMESCO Finland

Physiotherapist

1.9

105.6

1698

9935

S06.0

ICD-10 Finland

Concussion

2.1

104.7

1121

5699

M25.5

ICD-10 Finland

Pain in joint

1.7

104.6

3125

21760

C07AB07

ATC

bisoprolol; oral

1.6

104.2

3609

26067

T78.9

ICD-10 Finland

Adverse effect, unspecified

347.7

103.4

104

Z71.8

ICD-10 Finland

Other specified counselling

1.6

103.3

3121

21780

D07AA02

ATC

hydrocortisone; topical

1.9

103.0

1528

8706

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

101.5

2785

18943

P01AB01

ATC

metronidazole; oral, rectal

1.6

101.0

3780

27757

M03BX02

ATC

tizanidine; oral

1.6

100.6

5757

46665

R4110

NOMESCO Finland

Physiotherapy

1.7

100.1

2434

16029

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

99.6

3899

28905

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

97.9

1724

10349

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

96.0

843

3959

J01DA01

ATC

[U] cefalexin

1.6

95.6

5629

45662

E000001, ,

ATC

1.7

95.5

2011

12706

Y34

ICD-10 Finland

Unspecified event, undetermined intent

8.2

95.1

126

155

R53

ICD-10 Finland

Malaise and fatigue

1.7

94.7

2285

14979

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

20.1

94.1

N03AX12

ATC

[U] gabapentin; oral

1.9

93.9

1483

8598

J01FA09

ATC

clarithromycin; systemic

1.6

93.5

2999

21119

R03BB04

ATC

tiotropium bromide; inhalant

2.3

92.8

802

3739

N05BA04

ATC

oxazepam; oral

1.7

92.1

2400

16035

D07AC01

ATC

betamethasone; topical

1.6

92.1

3212

23059

N05BB01

ATC

hydroxyzine; systemic

2.4

91.1

682

2989

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

90.5

1421

8216

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

452.1

90.4

R03BA01

ATC

beclometasone; inhalant

1.9

90.3

1317

7436

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

90.1

911

4520

J30.3

ICD-10 Finland

Other allergic rhinitis

2.8

88.3

473

1765

N06AX21

ATC

duloxetine; oral

1.9

88.2

1191

6551

Y98

ICD-10 Finland

Lifestyle-related condition

12.6

88.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

87.3

3293

24000

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

87.0

1201

6653

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

86.9

1261

7101

R01AD12

ATC

fluticasone furoate; nasal

1.6

86.7

3238

23536

R50.9

ICD-10 Finland

Fever, unspecified

1.8

86.1

1442

8493

R01AD58

ATC

fluticasone, combinations; nasal

1.6

85.6

2563

17673

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

85.6

1282

7292

D07AC13

ATC

mometasone; topical

1.6

84.8

2585

17896

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

84.7

2502

17189

Z2221

NOMESCO Finland

Medical doctor

1.6

84.0

2549

17621

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

84.0

2164

14364

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

83.2

1019

5416

ZXE00

NOMESCO Finland

One hour or less

1.5

83.2

3517

26221

L03

ICPC

Low back symptom/complaint

1.6

82.4

2614

18248

A02BA02

ATC

ranitidine; systemic

1.8

82.3

1510

9129

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

82.0

763

3659

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

80.5

936

4881

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

78.8

826

4145

C08CA01

ATC

amlodipine; oral

1.6

78.7

2649

18710

N05BA01

ATC

diazepam; systemic, rectal

1.9

78.5

1125

6296

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

78.3

1836

11864

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

78.0

829

4181

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

4.6

77.8

188

418

WX892

NOMESCO Finland

Monitored bed care

2.3

77.8

662

3061

R06.4

ICD-10 Finland

Hyperventilation

3.9

77.5

228

589

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

77.0

1226

7092

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

76.3

1049

5788

R11

ICD-10 Finland

Nausea and vomiting

2.0

76.3

885

4607

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

76.2

369

1303

A02BC01

ATC

omeprazole; systemic

1.6

75.9

2294

15776

UJF32

NOMESCO Finland

Coloscopy

1.6

75.8

2052

13737

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

75.6

2265

15541

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

75.3

1211

7024

J02AC01

ATC

fluconazole; systemic

1.5

75.3

3871

29894

M79.1

ICD-10 Finland

Myalgia

1.8

75.1

1435

8757

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

74.7

660

3097

R03AC13

ATC

formoterol; inhalant

2.5

74.1

490

2027

C03CA01

ATC

furosemide; systemic

1.6

73.6

1856

12196

J01MA14

ATC

moxifloxacin; systemic

2.1

73.2

777

3914

R05

ICPC

Cough

1.6

73.1

2267

15664

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

72.2

966

5279

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

72.2

2861

20875

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

71.7

954

5202

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

71.6

467

1918

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

71.5

1362

8296

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.6

71.4

238

670

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

71.3

925

5001

R74

ICPC

Upper respiratory infection acute

1.5

71.2

3405

25821

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

71.0

1201

7065

M79.7

ICD-10 Finland

Fibromyalgia

2.6

70.4

423

1671

WX002

NOMESCO Finland

Sedation and analgesia

1.7

70.3

1564

9934

K30

ICD-10 Finland

Functional dyspepsia

1.9

70.1

1065

6061

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

70.0

2968

21937

N05AH04

ATC

quetiapine; oral

1.7

69.9

1696

11017

N30.0

ICD-10 Finland

Acute cystitis

1.7

69.7

1574

10036

N06AX11

ATC

mirtazapine; oral

1.5

69.6

2958

21869

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

69.5

399

1540

R03BA08

ATC

ciclesonide; inhalant

2.0

69.4

847

4484

N06AX16

ATC

venlafaxine; oral

1.7

69.2

1419

8815

A01

ICPC

Pain general/multiple sites

2.0

69.1

838

4426

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

68.9

2117

14565

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

68.2

2559

18403

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

67.9

2152

14902

R06AX26

ATC

fexofenadine; oral

2.1

67.9

736

3733

J45.8

ICD-10 Finland

Mixed asthma

2.9

67.8

336

1201

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

67.8

584

2710

A02BC03

ATC

lansoprazole; oral

1.6

67.5

2252

15775

R03AC12

ATC

salmeterol; inhalant

2.6

67.4

403

1588

S18

ICPC

Laceration/cut

1.5

66.9

3703

28808

T74.1

ICD-10 Finland

Physical abuse

4.2

66.9

182

444

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

66.1

4373

35172

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

66.0

3847

30203

R07.3

ICD-10 Finland

Other chest pain

1.9

65.4

870

4737

L17

ICPC

Foot/toe symptom/complaint

1.5

65.1

2483

17890

D01

ICPC

Abdominal pain/cramps general

1.7

65.0

1229

7453

N03AX09

ATC

lamotrigine; oral

2.2

64.7

559

2596

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

64.5

1051

6102

A03

ICPC

Fever

1.6

64.1

1779

11921

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

63.8

1231

7506

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

62.9

1502

9693

S29

ICPC

Skin symptom/complaint other

1.6

62.8

1659

10980

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

62.7

950

5392

G47.3

ICD-10 Finland

Sleep apnoea

1.6

62.6

1757

11798

H01

ICPC

Ear pain/earache

1.7

62.3

1218

7452

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

61.9

494

2220

D11

ICPC

Diarrhoea

1.7

61.8

1223

7505

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

61.8

358

1388

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

61.2

829

4539

R52.9

ICD-10 Finland

Pain, unspecified

1.9

61.0

898

5049

R01AD05

ATC

budesonide; nasal

2.0

60.3

710

3705

A46

ICD-10 Finland

Erysipelas

1.8

60.3

1050

6211

M01AE02

ATC

naproxen; oral, rectal

1.4

60.3

5222

43825

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

60.2

1871

12850

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

59.9

6644

58318

R00.2

ICD-10 Finland

Palpitations

1.9

59.7

776

4190

N06AB04

ATC

citalopram; systemic

1.6

59.6

1791

12201

N05CF01

ATC

zopiclone; oral

1.5

59.5

2484

18172

R21

ICPC

Throat symptom/complaint

1.5

58.7

2325

16817

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

58.5

886

5023

L12

ICPC

Hand/finger symptom/complaint

1.6

58.4

1509

9914

L50

ICD-10 Finland

Urticaria

3.1

58.2

246

804

N02AA05

ATC

oxycodone; systemic

1.7

58.1

1184

7316

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

58.1

357

1425

R55

ICD-10 Finland

Syncope and collapse

1.9

58.0

840

4696

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.1

58.0

550

2650

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

57.9

643

3285

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

57.8

2517

18553

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

57.2

800

4421

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

57.2

417

1801

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

57.1

4987

41732

D11AH01

ATC

tacrolimus; topical

4.1

57.0

158

391

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

8.2

56.8

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

56.6

462

2094

J20

ICD-10 Finland

Acute bronchitis

1.8

56.4

919

5324

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

56.4

745

4041

A04

ICPC

Weakness/tiredness general

1.6

56.3

1350

8700

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

56.2

1271

8070

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

56.1

803

4470

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

56.0

1069

6484

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

56.0

1190

7432

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

55.9

695

3693

R06.2

ICD-10 Finland

Wheezing

2.3

55.7

457

2076

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

55.5

637

3292

E000002, ,

ATC

1.7

55.4

1083

6610

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

55.3

811

4549

C07AA05

ATC

propranolol; systemic

1.5

55.2

1884

13178

S80.0

ICD-10 Finland

Contusion of knee

1.9

54.8

731

3977

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

54.2

1260

8051

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

54.2

1095

6744

M01AB05

ATC

diclofenac; systemic, rectal

1.4

54.0

5641

48462

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

54.0

804

4531

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

53.9

900

5251

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

53.8

6776

60152

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

53.5

419

1867

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

53.4

2269

16596

N06AB10

ATC

escitalopram; oral

1.5

53.3

2007

14320

M01AH05

ATC

etoricoxib; oral

1.4

53.1

5302

45139

Z00.8

ICD-10 Finland

Other general examinations

1.9

53.0

719

3931

L01

ICPC

Neck symptom/complaint

1.6

53.0

1439

9546

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.7

53.0

292

1104

SPAT1254

SPAT

Administration of medicine

1.6

52.8

1243

7962

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

52.8

783

4406

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

52.6

518

2530

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

52.5

953

5695

B02AA02

ATC

tranexamic acid; systemic

1.6

52.4

1381

9094

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

52.4

2745

20890

L28

ICPC

Limited function/disability (L)

1.6

52.2

1242

7975

X12

ICD-10 Finland

Contact with other hot fluids

5.3

52.2

105

200

R05

ICD-10 Finland

Cough

1.5

51.9

1852

13056

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

51.8

569

2894

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

51.7

808

4619

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

51.5

393

1731

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.8

51.2

115

241

344

Kela drug reimbursment

Omalizumab

12.6

51.2

Z00.0

ICD-10 Finland

General medical examination

1.5

50.9

1655

11430

N01

ICPC

Headache

1.6

50.9

1241

8014

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

50.9

4067

33270

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

50.6

385

1693

R07.0

ICD-10 Finland

Pain in throat

1.8

50.3

748

4209

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

49.9

2321

17243

J01FA01

ATC

erythromycin; systemic

1.6

49.7

1347

8923

J01EA01

ATC

trimethoprim; systemic

1.5

49.6

2268

16788

Y96.8

ICD-10 Finland

Other type of accident

5.0

49.4

106

214

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

49.3

580

3022

WZC30

NOMESCO Finland

Teaching

1.6

48.9

1234

8030

R01AD01

ATC

beclometasone; nasal

1.6

48.9

1317

8706

R52.2

ICD-10 Finland

Other chronic pain

2.4

48.8

351

1506

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

48.7

684

3779

ZY010

NOMESCO Finland

Hospital outpatient

2.0

48.7

551

2832

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

48.6

4772

40250

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

48.2

447

2133

K08.80

ICD-10 Finland

Toothache NOS

1.8

47.8

850

5043

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

47.8

348

1502

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

47.7

471

2302

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

47.6

717

4049

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

47.6

440

2097

A12

ICPC

ALLERGY/ALLERGIC REACTION

6.8

47.4

110

E000003, ,

ATC

2.2

47.2

419

1964

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

47.1

2425

18321

W19

ICD-10 Finland

Unspecified fall

1.8

47.0

793

4632

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

47.0

588

3128

D06

ICPC

Abdominal pain localized other

1.8

47.0

839

4983

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

46.8

1020

6394

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

46.8

760

4391

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

46.7

687

3852

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

46.1

441

2130

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

45.8

1037

6563

N17

ICPC

Vertigo/dizziness

1.7

45.5

964

5995

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

45.3

2796

21785

R13

ICD-10 Finland

Dysphagia

2.0

45.1

539

2821

J01DA09

ATC

[U] cefadroxil

1.4

44.8

2258

16967

D02

ICPC

Abdominal pain epigastric

1.9

44.8

579

3113

A01AB09

ATC

miconazole; local oral

1.8

44.7

697

3976

A11

ICPC

Chest pain NOS

1.9

44.7

630

3484

L15

ICPC

Knee symptom/complaint

1.5

44.6

1944

14212

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

44.6

1491

10330

J05AB01

ATC

aciclovir; systemic

1.5

44.4

1846

13371

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

44.3

1037

6616

ZXD05

NOMESCO Finland

Urgent procedure

1.4

44.0

2545

19588

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

43.9

473

2387

E66.8

ICD-10 Finland

Other obesity

1.9

43.9

547

2905

R03DX05

ATC

omalizumab; parenteral

12.3

43.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

43.5

840

5096

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.4

43.3

291

1211

T75.4

ICD-10 Finland

Effects of electric current

7.6

42.8

F29

ICPC

Eye symptom/complaint other

1.7

42.7

834

5074

A10BA02

ATC

metformin; oral

1.5

42.7

1869

13664

S21

ICPC

Skin texture symptom/complaint

1.6

42.5

1142

7527

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

42.5

2435

18691

R12

ICD-10 Finland

Heartburn

1.8

42.3

703

4085

N06AB06

ATC

sertraline; oral

1.6

42.0

1063

6909

E000006, ,

ATC

1.9

41.9

582

3201

R01AD11

ATC

triamcinolone; nasal

1.7

41.7

751

4467

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

41.6

636

3604

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

3.6

41.4

139

394

Y94.0

ICD-10 Finland

Accident at home

3.2

41.4

169

542

L16

ICPC

Ankle symptom/complaint

1.6

41.2

1032

6687

P01

ICPC

Feeling anxious/nervous/tense

1.5

41.0

1350

9309

R03DA04

ATC

theophylline; systemic, rectal

2.2

40.9

352

1630

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

40.8

3280

26563

S01GX02

ATC

levocabastine; ophthalmic

1.9

40.6

559

3067

XF404

NOMESCO Finland

Ambulatory ECG

1.8

40.5

635

3626

L02

ICPC

Back symptom/complaint

1.6

40.5

932

5915

UKC02

NOMESCO Finland

Cystoscopy

1.6

40.3

983

6327

D07AD01

ATC

clobetasol; topical

1.5

40.2

1332

9195

J01MA06

ATC

norfloxacin; oral

1.6

40.1

1018

6616

B01AB05

ATC

enoxaparin; parenteral

1.4

39.9

2312

17747

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

39.8

377

1813

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

39.8

952

6098

C09CA06

ATC

candesartan; oral

1.4

39.8

1807

13279

J01DC02

ATC

cefuroxime; systemic

1.9

39.7

502

2677

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

39.6

1388

9690

ZXA00

NOMESCO Finland

Right side

1.4

39.6

1851

13674

Z2445

NOMESCO Finland

Psychologist

2.0

39.5

419

2103

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

39.4

1044

6851

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

39.2

1328

9204

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

39.2

577

3231

ZXA10

NOMESCO Finland

Bilateral

1.5

39.2

1380

9643

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

39.2

239

951

H92.0

ICD-10 Finland

Otalgia

1.8

39.1

599

3396

Z2446

NOMESCO Finland

Social worker

1.8

39.1

588

3315

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

64.5

39.1

C03DA01

ATC

spironolactone; oral

1.7

38.8

767

4677

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

38.8

1015

6642

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

38.6

3107

25115

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

38.5

948

6112

J04.0

ICD-10 Finland

Acute laryngitis

2.0

38.5

413

2080

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

38.3

847

5317

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

38.3

668

3935

WX402

NOMESCO Finland

General anaesthesia

1.4

38.2

1773

13068

ZX120

NOMESCO Finland

Intravenous

1.7

38.0

725

4379

J01DA06

ATC

[U] cefuroxime

1.5

37.9

1164

7896

R10.0

ICD-10 Finland

Acute abdomen

2.3

37.8

297

1324

M54.2

ICD-10 Finland

Cervicalgia

1.7

37.8

679

4032

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.6

37.7

199

R51

ICD-10 Finland

Headache

1.8

37.5

557

3128

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

37.4

521

2867

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

37.3

602

3466

S02

ICPC

Pruritus

2.1

37.2

340

1613

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

37.2

1146

7779

M01AH01

ATC

celecoxib; oral

1.5

37.1

1298

9050

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

37.1

2037

15460

T90

ICPC

Diabetes non-insulin dependent

1.5

37.0

1509

10848

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

36.8

597

3442

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

9.6

36.8

U02

ICPC

Urinary frequency/urgency

1.5

36.6

1177

8059

A99

ICPC

Disease/condition unspecnature/site

1.7

36.5

728

4446

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

36.5

372

1839

R29

ICPC

Respiratory symptom/complaint other

1.8

36.5

576

3295

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

36.4

1669

12263

N03AE01

ATC

clonazepam; systemic

1.9

36.4

456

2425

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

36.3

1329

9349

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

36.3

1865

13987

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

36.2

786

4908

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

36.1

530

2964

D11AX14

ATC

[U] tacrolimus

4.8

36.1

170

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

36.0

311

1442

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

35.9

1403

9996

L08

ICPC

Shoulder symptom/complaint

1.4

35.8

1659

12211

H57.1

ICD-10 Finland

Ocular pain

2.1

35.7

362

1786

D02AX

ATC

Other emollients and protectives

2.2

35.7

320

1507

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

35.5

761

4735

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

35.5

325

1543

A29

ICPC

General symptom/complaint other

1.6

35.5

936

6131

C07AB02

ATC

metoprolol; systemic

1.5

35.4

1235

8598

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

35.1

566

3258

SPAT1260

SPAT

Consultation of another employee

1.5

35.0

1403

10041

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

35.0

895

5817

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

35.0

1657

12236

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

35.0

471

2564

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.0

34.9

399

2055

ZXA05

NOMESCO Finland

Left side

1.4

34.8

1698

12605

R4120

NOMESCO Finland

Occupational therapy

1.8

34.8

533

3020

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

34.7

436

2319

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.8

34.7

545

3112

N06AA09

ATC

amitriptyline; systemic

1.7

34.7

688

4196

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

34.6

452

2435

S01GX08

ATC

ketotifen; ophthalmic

1.9

34.6

429

2272

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

34.6

694

4244

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

34.6

481

2645

SPAT1283

SPAT

Restricted health certificate

1.4

34.5

1850

13957

N89

ICPC

Migraine

1.9

34.5

420

2211

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

34.4

228

943

A08

ICPC

Swelling

2.0

34.4

372

1879

M54

ICD-10 Finland

Dorsalgia

1.5

34.4

1088

7418

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

34.3

484

2675

SPAT1263

SPAT

Sampling

1.3

34.1

3575

29878

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

34.1

182

678

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

34.1

2055

15812

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.4

34.0

227

942

Z50.1

ICD-10 Finland

Other physical therapy

2.0

33.9

406

2126

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

33.9

595

3509

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

33.8

354

1768

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

33.8

1608

11877

M04AA01

ATC

allopurinol; systemic

1.7

33.7

714

4428

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

33.7

480

2660

M02AA07

ATC

piroxicam; topical

1.3

33.7

2565

20466

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

33.6

510

2881

A06AD11

ATC

lactulose; oral

1.6

33.5

919

6069

K02.1

ICD-10 Finland

Caries of dentine

1.3

33.5

5369

47464

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.0

33.4

236

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

33.3

552

3202

SFA20

NOMESCO Finland

Two-surface restoration

1.3

33.2

5203

45833

N02BF02

ATC

pregabalin; oral

1.8

33.1

478

2660

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

10.6

33.1

S01

ICPC

Pain/tenderness of skin

2.0

33.0

383

1983

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.0

33.0

238

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.0

33.0

373

1915

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

3.5

32.9

113

326

D11AH02

ATC

pimecrolimus; topical

4.7

32.8

160

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

32.8

692

4288

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

32.8

511

2911

R4190

NOMESCO Finland

Nutritional therapy

2.0

32.7

358

1816

G43.3

ICD-10 Finland

Complicated migraine

2.5

32.7

205

827

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

32.6

450

2469

D02AE01

ATC

carbamide; topical

1.8

32.5

533

3082

J01FA15

ATC

telithromycin; oral

1.6

32.4

786

5042

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

32.3

1012

6882

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

32.2

323

1588

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

32.1

2702

21846

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

32.1

536

3116

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

32.0

2002

15470

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

32.0

779

5001

C08CA13

ATC

lercanidipine; oral

1.6

32.0

888

5879

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.9

32.0

155

549

A28

ICPC

Limited function/disability NOS

1.5

31.9

978

6617

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

31.9

607

3658

R01AC01

ATC

cromoglicic acid; nasal

2.0

31.9

363

1868

D11AH05

ATC

dupilumab; topical

7.5

31.8

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

31.7

198

797

Z01.7

ICD-10 Finland

Laboratory examination

1.5

31.7

1184

8345

N05CF02

ATC

zolpidem; oral

1.4

31.7

1385

10060

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

31.6

2155

16875

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

31.6

549

3226

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

31.4

1678

12631

338

Kela drug reimbursment

C1-esterase inhibitor, icatibant and conestat alfa

+∞

31.3

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.5

31.2

108

313

L29

ICPC

Musculoskeletal sympt/complt other

1.6

31.1

677

4226

WVA20

NOMESCO Finland

Medicine administration

2.4

31.1

212

889

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

31.0

308

1508

L20

ICD-10 Finland

Atopic dermatitis

2.0

30.9

320

1591

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

30.9

351

1804

SFA30

NOMESCO Finland

Three-surface restoration

1.3

30.9

3359

28102

A07AA02

ATC

nystatin; oral

1.9

30.9

423

2315

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.9

30.8

395

2115

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

30.8

633

3894

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

30.6

796

5188

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

30.6

857

5682

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

30.6

744

4775

J30.19

ICD-10 Finland

Pollen allergy UNS

1.9

30.6

390

2086

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

30.5

859

5703

395

Kela drug reimbursment

Dupilumab

7.4

30.5

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

30.4

3134

26018

XQ830

NOMESCO Finland

Exposure to foodstuff

9.8

30.3

R51.81

ICD-10 Finland

Facial pain NOS

2.3

30.3

227

993

SPAT1310

SPAT

Counselling related to known health issue

1.3

30.3

2616

21195

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.2

30.2

119

374

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

30.1

470

2677

B01AC04

ATC

clopidogrel; oral

1.5

30.1

867

5785

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

30.1

432

2400

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

29.9

984

6755

C09AA02

ATC

enalapril; systemic

1.5

29.9

1125

7937

J05AB11

ATC

valaciclovir; oral

1.5

29.9

1149

8140

U01

ICPC

Dysuria/painful urination

1.6

29.8

685

4334

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

29.8

1729

13183

N05BA12

ATC

alprazolam; oral

1.6

29.7

754

4887

SFA10

NOMESCO Finland

One-surface restoration

1.3

29.6

4881

42982

A03FA02

ATC

cisapride; oral, rectal

1.7

29.6

515

3027

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

29.6

380

2036

P03

ICPC

Feeling depressed

1.5

29.5

995

6864

J01CA04

ATC

amoxicillin; systemic

1.4

29.5

7549

70436

K80

ICPC

Cardiac arrhythmia NOS

1.7

29.4

576

3497

SPAT1211

SPAT

Application of soft bandage

1.6

29.3

694

4424

B06AC02

ATC

icatibant; parenteral

+∞

29.2

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

29.1

433

2430

Z01.2

ICD-10 Finland

Dental examination

1.3

29.1

4117

35543

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

29.1

556

3355

D10

ICPC

Vomiting

1.7

29.1

621

3858

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

2.8

29.0

150

550

N03AG01

ATC

valproic acid; systemic, rectal

1.8

28.9

476

2754

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

28.9

397

2174

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

28.9

3426

28919

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

28.8

299

1489

D84.13

ICD-10 Finland

Hereditary angioedema type III

292.9

28.8

N06AX26

ATC

vortioxetine; oral

1.6

28.8

653

4118

L30.3

ICD-10 Finland

Infective dermatitis

2.1

28.7

282

1375

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

28.7

545

3281

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.9

28.7

348

1830

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

28.7

265

1263

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

28.6

572

3492

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

28.5

2529

20528

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

28.5

465

2683

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.2

28.5

111

347

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

28.4

811

5396

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

28.4

1029

7201

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

28.3

1210

8738

L20

ICPC

Joint symptom/complaint NOS

2.0

28.3

312

1587

D06AX01

ATC

fusidic acid; topical

1.6

28.3

762

5004

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.0

28.3

321

1650

R97

ICPC

Allergic rhinitis

2.3

28.3

215

947

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

28.2

672

4287

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

28.2

160

615

S04

ICPC

Lump/swelling localized

1.5

28.2

857

5784

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

28.0

1489

11173

L04AX03

ATC

methotrexate; systemic

1.6

27.9

767

5060

I20.09

ICD-10 Finland

Unstable angina

2.0

27.8

310

1583

D84.11

ICD-10 Finland

Hereditary angioedema type I

282.4

27.8

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

27.7

443

2541

R83

ICPC

Respiratory infection other

1.3

27.7

2485

20191

D09

ICPC

Nausea

1.8

27.7

465

2707

P76

ICPC

Depressive disorder

1.6

27.6

627

3955

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

3.5

27.6

270

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.1

27.6

281

1390

C09AA05

ATC

ramipril; oral

1.4

27.6

1412

10529

XF402

NOMESCO Finland

ECG with work load test

1.6

27.5

659

4210

S76

ICPC

Skin infection other

1.8

27.5

393

2180

P06

ICPC

Sleep disturbance

1.5

27.5

992

6935

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

27.4

956

6635

M89.0

ICD-10 Finland

Algoneurodystrophy

3.3

27.3

100

301

WX290

NOMESCO Finland

Other blockage of nerve

1.3

27.3

4284

37354

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

27.1

591

3688

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

27.1

1667

12804

M54.1

ICD-10 Finland

Radiculopathy

2.0

27.1

313

1619

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

27.0

986

6906

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

27.0

390

2170

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.9

27.0

326

1712

A02BC04

ATC

rabeprazole; oral

1.6

27.0

686

4445

H02AB09

ATC

hydrocortisone; systemic

2.2

27.0

223

1017

M01AX17

ATC

nimesulide; oral

1.4

26.9

1574

11995

R25.2

ICD-10 Finland

Cramp and spasm

2.3

26.8

203

892

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

26.8

431

2476

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.6

26.7

247

L14

ICPC

Leg/thigh symptom/complaint

1.6

26.6

592

3715

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

2.8

26.5

129

458

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

26.5

478

2837

M10.9

ICD-10 Finland

Gout, unspecified

1.8

26.5

371

2044

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

26.5

464

2733

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

26.3

714

4696

K04

ICPC

Palpitations/awareness of heart

1.8

26.3

416

2379

SPAT1104

SPAT

Monitoring of emergency patient

1.7

26.3

467

2762

SPAT1255

SPAT

Intravenous administration of medicine

1.7

26.2

472

2800

L11

ICPC

Wrist symptom/complaint

1.5

26.2

781

5243

G43.8

ICD-10 Finland

Other migraine

2.4

26.2

174

722

JAH01

NOMESCO Finland

Laparoscopy

1.8

26.1

386

2164

S88

ICPC

Dermatitis contact/allergic

2.3

26.1

194

847

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

26.0

456

2685

K04.0

ICD-10 Finland

Pulpitis

1.5

25.9

818

5559

G43

ICD-10 Finland

Migraine

1.7

25.9

549

3402

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

25.9

3303

28027

S01GX09

ATC

olopatadine; ophthalmic

2.1

25.9

254

1239

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

25.9

904

6274

N76.0

ICD-10 Finland

Acute vaginitis

1.6

25.9

667

4335

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

25.9

355

1944

N06AB03

ATC

fluoxetine; oral

1.5

25.9

969

6820

A97

ICPC

No disease

1.4

25.8

1432

10809

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

25.8

651

4209

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

25.8

405

2311

R03BC01

ATC

cromoglicic acid; inhalant

2.6

25.7

150

585

Y94.8

ICD-10 Finland

Other leisure activity accident

2.2

25.7

229

1076

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

25.6

817

5565

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.7

25.6

134

495

SPAT1312

SPAT

General health counselling

1.3

25.6

2725

22600

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

25.6

435

2541

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

25.5

537

3321

M54.3

ICD-10 Finland

Sciatica

1.7

25.5

455

2693

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

25.5

606

3863

N06AX12

ATC

bupropion; oral

1.6

25.5

656

4261

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

25.5

229

1080

R03BC03

ATC

nedocromil; inhalant

1.7

25.5

501

3044

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.1

25.5

107

350

KH1AD

NOMESCO Finland

CT of urinary organs

2.1

25.5

250

1220

S12

ICPC

Insect bite/sting

1.6

25.3

593

3768

R33

ICD-10 Finland

Retention of urine

1.8

25.3

415

2399

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

25.3

393

2236

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

25.3

529

3268

H53.2

ICD-10 Finland

Diplopia

2.1

25.3

240

1157

L04

ICPC

Chest symptom/complaint

1.7

25.1

486

2940

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.9

25.0

309

1635

C07AB12

ATC

nebivolol; oral

2.2

25.0

216

1004

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

24.8

6193

56712

A04AA01

ATC

ondansetron; systemic, rectal

1.6

24.8

589

3754

WX320

NOMESCO Finland

Spinalanesthesy

1.3

24.8

1730

13530

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

24.7

850

5880

SPAT1252

SPAT

Overall medication plan or its review

1.8

24.7

414

2408

J33.8

ICD-10 Finland

Other polyp of sinus

2.5

24.7

153

615

N02BF01

ATC

gabapentin; oral

1.6

24.7

616

3973

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

24.5

247

P29

ICPC

Psychological sympt/compl other

1.6

24.5

674

4446

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

24.5

283

1465

V01AA05

ATC

tree pollen; parenteral

3.2

24.4

297

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

24.4

1398

10599

E000007, ,

ATC

1.7

24.3

465

2804

P74

ICPC

Anxiety disorder/anxiety state

1.7

24.3

429

2533

H01.0

ICD-10 Finland

Blepharitis

1.6

24.2

547

3444

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

24.1

516

3207

N30

ICD-10 Finland

Cystitis

1.5

24.0

711

4764

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

24.0

208

967

K04.08

ICD-10 Finland

Other specified pulpit

1.6

24.0

656

4320

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

24.0

571

3642

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.0

23.8

270

1388

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

23.8

292

1542

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

23.7

441

2640

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

23.7

183

812

A10BH01

ATC

sitagliptin; oral

1.6

23.7

552

3502

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

23.6

1111

8151

S98

ICPC

Urticaria

3.4

23.5

254

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

23.4

710

4783

C08DA01

ATC

verapamil; systemic

2.0

23.4

270

1397

SGA01

NOMESCO Finland

Emergency treatment

1.4

23.4

1356

10296

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

23.3

432

2583

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

23.3

473

2898

C02AC05

ATC

moxonidine; oral

1.9

23.3

275

1434

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

23.2

396

2314

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

23.2

639

4213

205

Kela drug reimbursment

Chronic hypertension

1.4

23.2

1415

10828

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

23.2

659

4376

H03AA01

ATC

levothyroxine sodium; systemic

1.3

23.2

1814

14404

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.9

23.1

279

1466

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

23.1

169

733

C10AA05

ATC

atorvastatin; oral

1.3

23.1

2484

20572

K07.60

ICD-10 Finland

Snapping jaw

1.7

23.1

479

2952

SPAT1240

SPAT

Therapeutic discussion

1.4

23.1

981

7064

R09

ICPC

Sinus symptom/complaint

1.5

22.9

738

5033

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

22.9

371

2136

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

22.9

1810

14387

XA402

NOMESCO Finland

ENMG

2.2

22.9

198

921

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

22.8

176

781

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

22.8

219

1061

K07

ICPC

Swollen ankles/oedema

1.9

22.8

277

1459

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.9

22.7

170

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.6

22.7

202

R4140

NOMESCO Finland

Psychotherapy

3.5

22.7

221

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

22.7

222

1083

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

22.7

1027

7480

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

22.6

273

1435

N03AX11

ATC

topiramate; oral

2.0

22.5

237

1187

U07

ICPC

Urine symptom/complaint other

1.6

22.5

510

3213

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.1

22.5

213

1026

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.8

22.5

348

1978

WX722

NOMESCO Finland

PEEP

1.9

22.5

291

1565

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

22.4

866

6124

TAB00

NOMESCO Finland

Lumbar puncture

1.8

22.4

367

2122

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.2

22.4

195

910

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

22.3

584

3809

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

22.2

262

1366

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

22.2

450

2758

J01

ICD-10 Finland

Acute sinusitis

1.6

22.2

489

3061

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

22.1

3449

29802

ZX112

NOMESCO Finland

Subcutaneous

2.3

22.1

162

703

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

22.1

311

1718

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

22.0

392

2319

R06.5

ICD-10 Finland

Mouth breathing

1.5

22.0

641

4282

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

21.9

707

4823

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

21.9

848

5999

EBA00

NOMESCO Finland

Extraction of tooth

1.3

21.9

2941

24981

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

21.8

873

6216

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

21.7

491

3092

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

21.7

538

3464

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.0

21.6

228

1143

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

21.6

310

1722

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

21.6

238

1212

U71

ICPC

Cystitis/urinary infection other

1.6

21.6

533

3428

S87

ICPC

Dermatitis/atopic eczema

2.0

21.6

223

1110

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

21.5

278

1494

L13

ICPC

Hip symptom/complaint

1.4

21.5

1224

9256

W80

ICD-10 Finland

Inhalation and ingestion of other objects causing obstruction of respiratory tract

8.7

21.5

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

21.4

336

1918

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

21.4

528

3397

S97

ICPC

Chronic ulcer skin

1.8

21.3

344

1979

KMAK, ,

NOMESCO Finland

1.2

21.3

4414

39278

SPAT1262

SPAT

Handing over of treatment supplies

1.4

21.3

1115

8320

R4110, ,

SPAT

1.5

21.3

596

3945

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

21.3

799

5619

R75

ICPC

Sinusitis acute/chronic

1.7

21.3

413

2502

M48.0

ICD-10 Finland

Spinal stenosis

1.5

21.2

688

4697

C08CA05

ATC

nifedipine; systemic

1.7

21.2

375

2214

A02BA04

ATC

nizatidine; systemic

1.6

21.2

450

2789

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

21.2

232

1179

R5110, ,

SPAT

1.7

21.2

410

2482

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.7

21.2

115

434

S20.2

ICD-10 Finland

Contusion of thorax

1.7

21.2

359

2096

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

21.1

249

1298

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

21.1

970

7076

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.8

21.1

101

357

SPAT1058

SPAT

PEF monitoring instruction

1.5

21.0

584

3858

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

21.0

219

1094

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.3

21.0

159

701

-1, ,

NOMESCO Finland

1.3

20.9

2929

24965

N02CC04

ATC

rizatriptan; oral

1.6

20.9

499

3183

J32.4

ICD-10 Finland

Chronic pansinusitis

2.5

20.9

130

524

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

20.9

619

4147

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

20.9

950

6919

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.7

20.9

376

2232

R30.0

ICD-10 Finland

Dysuria

1.8

20.8

340

1964

T82

ICPC

Obesity

1.7

20.8

350

2040

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.7

20.7

177

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

20.7

426

2619

PA6AD

NOMESCO Finland

CT of neck arteries

2.1

20.7

200

971

C03AA03

ATC

hydrochlorothiazide; oral

1.6

20.7

511

3286

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

20.5

291

1611

C01DA14

ATC

isosorbide mononitrate; oral

1.5

20.5

692

4763

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.0

20.5

211

1049

M54.8

ICD-10 Finland

Other dorsalgia

1.7

20.5

359

2115

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

20.5

809

5742

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

20.5

1023

7572

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

20.4

177

825

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

20.4

631

4268

N03AF01

ATC

carbamazepine; oral, rectal

1.8

20.3

326

1874

G50.1

ICD-10 Finland

Atypical facial pain

2.3

20.2

150

655

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

20.2

242

1269

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.8

20.2

293

1634

J39.3

ICD-10 Finland

Upper respiratory tract hypersensitivity reaction, site unspecified

5.1

20.2

SPAT1281

SPAT

Other administrative function

1.5

20.2

598

4007

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

20.1

989

7298

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

20.1

954

6998

ZXD35

NOMESCO Finland

Usual procedure

2.0

20.0

228

1175

SPAT1216

SPAT

Assessment of functional ability

1.4

20.0

929

6787

S22.3

ICD-10 Finland

Fracture of rib

1.6

20.0

445

2791

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

20.0

332

1927

L86

ICPC

Back syndrome with radiating pain

1.6

20.0

440

2753

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

7.6

19.9

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.2

19.9

163

742

R60.1

ICD-10 Finland

Generalized oedema

3.4

19.9

206

RD210, ,

NOMESCO Finland

2.2

19.8

167

769

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

19.8

716

4995

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

19.8

889

6456

ZX114

NOMESCO Finland

Intramuscular

2.5

19.8

123

496

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

19.8

331

1925

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

19.8

195

955

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

19.7

2218

18407

JN4BD

NOMESCO Finland

Extensive body CT

1.5

19.7

625

4248

R06AX12

ATC

terfenadine; oral

1.7

19.7

355

2109

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

19.6

213

1080

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

19.6

591

3974

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

19.6

331

1931

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

19.6

201

999

H29

ICPC

Ear symptom/complaint other

1.4

19.5

802

5734

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

19.4

252

1357

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

19.4

225

1167

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.3

19.4

139

598

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

19.4

827

5951

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

19.4

922

6763

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.1

19.3

191

937

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

19.2

590

3983

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

19.2

576

3871

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.9

19.1

229

1201

R52.0

ICD-10 Finland

Acute pain

1.8

19.1

272

1508

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

19.1

746

5282

SPAT1097

SPAT

Recording of ECG

1.4

19.1

892

6523

R03DC01

ATC

zafirlukast; oral

2.5

19.1

117

469

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

19.1

377

2295

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.9

19.0

227

1189

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.0

19.0

205

1037

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

19.0

367

2220

UJD02

NOMESCO Finland

Gastroscopy

1.8

19.0

307

1768

S06

ICPC

Rash localized

1.6

19.0

404

2506

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.3

19.0

146

648

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

19.0

722

5087

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.0

19.0

279

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

2.9

19.0

295

F61.0

ICD-10 Finland

Mixed personality disorders

2.2

18.9

153

694

V01AA02

ATC

grass pollen; parenteral

3.9

18.9

138

XQ848

NOMESCO Finland

Dermatological photography

2.0

18.9

200

1006

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

18.9

172

818

N06AX03

ATC

mianserin; oral

1.8

18.9

311

1802

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

18.9

657

4551

S92.5

ICD-10 Finland

Fracture of other toe

1.9

18.8

235

1250

P01BA02

ATC

hydroxychloroquine; oral

1.5

18.8

603

4107

SPAT1301

SPAT

No procedures

1.3

18.8

2351

19734

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

3.7

18.8

161

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.3

18.8

139

607

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

18.7

825

5971

N05AX12

ATC

aripiprazole; systemic

1.7

18.7

351

2108

UDC00

NOMESCO Finland

Ear microscopy

1.5

18.7

540

3598

Y97

ICD-10 Finland

Environmental-pollution-related condition

70.0

18.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

18.7

784

5626

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

7.0

18.6

N06AX22

ATC

agomelatine; oral

2.0

18.6

204

1038

UJH02

NOMESCO Finland

Anoscopy

1.8

18.6

285

1617

E87.6

ICD-10 Finland

Hypokalaemia

2.0

18.5

213

1102

C10AA01

ATC

simvastatin; oral

1.3

18.5

2280

19098

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

18.5

296

1700

J01DA08

ATC

[U] cefaclor

1.4

18.5

1040

7843

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

3.5

18.5

182

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

18.5

755

5392

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

18.4

294

1687

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.7

18.4

346

2078

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.9

18.4

136

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

18.4

358

2170

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

18.4

335

1995

K59.0

ICD-10 Finland

Constipation

1.7

18.4

377

2317

S14

ICPC

Burn/scald

1.8

18.3

269

1506

S10

ICPC

Boil/carbuncle

1.6

18.3

412

2591

A13

ICPC

Concern/fear medical treatment

2.3

18.3

136

595

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.8

18.3

312

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

18.3

234

1255

R07

ICPC

Sneezing/nasal congestion

1.5

18.3

596

4074

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.9

18.2

307

ZXD20

NOMESCO Finland

Day surgery

1.4

18.2

928

6884

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

18.2

265

1480

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

18.2

174

843

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

4.1

18.2

120

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

18.1

209

1084

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

18.0

615

4241

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.3

18.0

129

556

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.5

18.0

110

441

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

18.0

370

2277

JN4AD

NOMESCO Finland

Body CT examination

1.5

17.9

585

3998

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

17.9

287

1651

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

2.8

17.8

300

C10AC01

ATC

colestyramine; oral

2.0

17.8

200

1027

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.9

17.8

222

1181

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

17.8

116

479

XQ810

NOMESCO Finland

Physical test for urticaria

7.2

17.8

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

17.8

197

1007

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

17.7

238

1297

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.0

17.7

192

975

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.0

17.6

259

B02.9

ICD-10 Finland

Zoster without complication

1.6

17.6

418

2664

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

17.6

986

7427

R2110

NOMESCO Finland

Giving the first information

1.5

17.6

535

3605

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

17.5

141

638

F01

ICPC

Eye pain

1.9

17.5

234

1273

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

17.5

149

690

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.8

17.5

266

1506

M77.4

ICD-10 Finland

Metatarsalgia

1.6

17.5

462

3019

K29.1

ICD-10 Finland

Other acute gastritis

2.6

17.4

377

M23.8

ICD-10 Finland

Other internal derangements of knee

1.7

17.4

290

1685

R03BB01

ATC

ipratropium bromide; inhalant

2.0

17.4

199

1028

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.0

17.4

193

987

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.1

17.4

164

791

N03AF02

ATC

oxcarbazepine; oral

1.8

17.2

246

1367

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.0

17.2

183

923

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.0

17.2

247

I50.0

ICD-10 Finland

Congestive heart failure

1.7

17.1

310

1845

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

5.4

17.1

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.4

17.1

114

476

R31

ICD-10 Finland

Unspecified haematuria

1.5

17.1

529

3578

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.6

17.0

100

393

SPAT1153

SPAT

Removal of sutures

1.2

17.0

2151

18042

B01AB10

ATC

tinzaparin; parenteral

1.4

17.0

666

4718

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

17.0

352

2171

A85

ICPC

Adverse effect medical agent

2.8

16.9

292

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

16.9

3027

26341

EB1VA, ,

NOMESCO Finland

1.4

16.9

933

7012

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

16.9

357

2213

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.4

16.9

662

4691

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

16.8

599

4165

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

16.8

239

1326

K03.80

ICD-10 Finland

Irradiated enamel

1.6

16.8

444

2901

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

16.7

526

3568

K08.3

ICD-10 Finland

Retained dental root

1.5

16.7

465

3075

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

16.7

196

1023

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.2

16.6

131

588

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

16.6

566

3904

GD1AA, ,

SPAT

1.4

16.6

957

7239

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

16.5

660

4692

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

16.5

197

1034

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

16.4

704

5069

N06AB05

ATC

paroxetine; oral

1.6

16.4

440

2885

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

16.4

197

1036

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

16.4

621

4371

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

16.4

168

836

1220

FHL

Arthroscopy

1.8

16.3

245

1382

SPAT1267

SPAT

Desensitisation

5.3

16.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

16.3

198

1045

J01CF05

ATC

flucloxacillin; systemic

1.5

16.3

443

2913

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

16.3

380

2412

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

16.3

340

2100

A10BK01

ATC

dapagliflozin; oral

1.6

16.3

401

2578

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

16.3

507

3432

N05AH03

ATC

olanzapine; systemic

1.5

16.3

458

3034

-60

ICPC

Result test/procedure

1.6

16.3

395

2531

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

16.3

148

704

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

16.3

249

1413

L01BA01

ATC

methotrexate; systemic

1.8

16.3

259

1487

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

16.3

330

2024

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

16.3

497

3352

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

16.2

117

507

D09AB01

ATC

zinc bandage without supplements; topical

2.2

16.1

136

628

K92.0

ICD-10 Finland

Haematemesis

2.2

16.1

140

654

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

16.1

164

814

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

16.1

337

2083

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

16.1

631

4471

R04.2

ICD-10 Finland

Haemoptysis

1.9

16.0

188

981

N05AE04

ATC

ziprasidone; systemic

3.1

16.0

220

L60.0

ICD-10 Finland

Ingrowing nail

1.6

16.0

348

2172

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.1

16.0

145

689

C08CA02

ATC

felodipine; oral

1.5

16.0

483

3249

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.9

16.0

199

1059

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

16.0

362

2282

D06BB03

ATC

aciclovir; topical

1.6

16.0

339

2103

R35

ICD-10 Finland

Polyuria

1.6

16.0

387

2480

A10BH05

ATC

linagliptin; oral

1.8

15.9

256

1474

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.0

15.9

168

845

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.7

15.9

275

1617

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

15.9

169

853

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.5

15.8

372

R04

ICPC

Breathing problem other

1.7

15.8

260

1507

G04CA02

ATC

tamsulosin; oral

1.3

15.8

975

7449

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

15.8

159

787

U13

ICPC

Bladder symptom/complaint other

1.9

15.7

201

1079

L50.2

ICD-10 Finland

Urticaria due to cold and heat

4.2

15.7

D07AC14

ATC

methylprednisolone aceponate; topical

1.6

15.7

327

2019

D19

ICPC

Teeth/gum symptom/complaint

1.2

15.7

2347

20020

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

15.7

527

3624

A10BJ02

ATC

liraglutide; parenteral

1.9

15.7

189

996

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

15.6

200

1074

N63

ICD-10 Finland

Unspecified lump in breast

1.5

15.6

539

3726

J01CA08

ATC

pivmecillinam; oral

1.2

15.6

3507

31123

L09

ICPC

Arm symptom/complaint

1.6

15.6

365

2319

A10BJ06

ATC

semaglutide; parenteral

1.7

15.6

312

1907

L20.8

ICD-10 Finland

Other atopic dermatitis

2.4

15.6

106

447

A27

ICPC

Fear of other disease NOS

1.6

15.6

333

2070

X28

ICD-10 Finland

Contact with other specified venomous plants

85.2

15.6

SGC10

NOMESCO Finland

Pulp capping

1.4

15.5

738

5409

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

3.7

15.5

130

E66

ICD-10 Finland

Obesity

1.6

15.5

412

2696

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

15.5

292

1757

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

15.5

164

826

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

15.4

241

1376

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

4.0

15.4

108

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

15.4

500

3413

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

15.4

410

2683

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

15.4

265

1555

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

15.4

227

1274

R01

ICPC

Pain respiratory system

2.1

15.4

136

640

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.4

15.4

100

413

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

15.4

281

1677

B01AB04

ATC

dalteparin; parenteral

1.6

15.3

339

2125

D07XC01

ATC

betamethasone; topical

1.4

15.3

777

5756

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

15.3

854

6423

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

15.3

299

1817

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

15.3

281

1680

N06AA10

ATC

nortriptyline; systemic

2.0

15.3

155

769

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.0

15.3

152

749

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.9

15.3

201

1090

J38.4

ICD-10 Finland

Oedema of larynx

3.6

15.2

141

F43.0

ICD-10 Finland

Acute stress reaction

1.5

15.2

494

3375

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

15.2

224

1258

S90.0

ICD-10 Finland

Contusion of ankle

2.0

15.2

165

839

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.5

15.2

392

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

15.1

174

902

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.1

15.1

140

671

F32

ICD-10 Finland

Depressive episode

1.5

15.1

457

3075

H10

ICD-10 Finland

Conjunctivitis

1.4

15.1

604

4294

D84.1

ICD-10 Finland

Defects in the complement system

20.0

15.1

Z91.0

ICD-10 Finland

Personal history of allergy, other than to drugs and biological substances

20.0

15.1

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

15.0

169

870

I20.00

ICD-10 Finland

Unstable angina

2.1

15.0

137

654

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

15.0

236

1352

N64.4

ICD-10 Finland

Mastodynia

1.7

15.0

281

1690

L04AD01

ATC

ciclosporin; systemic

2.1

14.9

142

688

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

14.9

1164

9190

S70.0

ICD-10 Finland

Contusion of hip

1.8

14.9

240

1384

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

3.1

14.9

193

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.0

14.8

151

750

H70

ICPC

Otitis externa

2.0

14.8

161

819

N05CD07

ATC

temazepam; oral

1.4

14.8

613

4387

-69

ICPC

Other reason for encounter NEC

1.7

14.8

257

1514

N06AX05

ATC

trazodone; oral

1.9

14.7

193

1045

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.7

323

2021

EMB10

NOMESCO Finland

Tonsillectomy

1.5

14.7

525

3653

R81

ICPC

Pneumonia

1.8

14.7

226

1285

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.2

14.7

116

522

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

14.7

204

1125

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

14.7

1521

12444

N05BA06

ATC

lorazepam; systemic, sublingual

1.6

14.7

302

1860

J01MA01

ATC

ofloxacin; systemic

1.5

14.6

479

3277

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.0

14.6

211

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.8

14.6

249

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

14.5

4583

41820

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.5

14.5

352

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

14.5

247

1446

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

2.8

14.5

255

N06AA12

ATC

doxepin; systemic

1.6

14.5

301

1858

L18

ICPC

Muscle pain

1.6

14.5

302

1866

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

14.5

234

1350

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

14.5

533

3731

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

3.6

14.4

132

M01AC06

ATC

meloxicam; systemic, rectal

1.2

14.4

2558

22161

J01AA04

ATC

lymecycline; systemic

1.3

14.4

1088

8551

L84

ICPC

Back syndrome without radiat pain

1.6

14.4

340

2166

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

14.4

1364

11039

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

14.4

307

1909

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

14.4

417

2783

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

14.4

499

3455

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

14.3

619

4461

F03

ICPC

Eye discharge

1.5

14.3

514

3583

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

14.3

533

3742

K04.09

ICD-10 Finland

Pulpit UNS

1.6

14.3

355

2290

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

14.2

360

2330

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

14.2

299

1852

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

14.2

297

1837

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

14.2

452

3077

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

14.2

1736

14475

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

14.1

565

4016

S50.0

ICD-10 Finland

Contusion of elbow

1.7

14.1

234

1360

N05BE01

ATC

buspirone; oral

1.8

14.1

199

1103

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.2

14.1

113

512

D11AX15

ATC

[U] pimecrolimus

4.2

14.1

M03BX01

ATC

baclofen; systemic

2.1

14.1

136

663

D03

ICPC

Heartburn

1.7

14.1

258

1542

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

14.1

341

2186

DPA30

NOMESCO Finland

Sphenotomy

3.1

14.1

184

A10BK03

ATC

empagliflozin; oral

1.4

14.1

533

3752

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

2.1

14.1

129

617

K85

ICPC

Elevated blood pressure

1.3

14.0

922

7105

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.7

14.0

116

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.6

14.0

317

R09.1

ICD-10 Finland

Pleurisy

2.1

14.0

132

638

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.0

14.0

147

740

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

13.9

382

2518

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

2.8

13.9

255

A01AB04

ATC

amphotericin B; local oral

1.7

13.9

262

1577

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

13.9

938

7254

S16

ICPC

Bruise/contusion

1.8

13.9

203

1137

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

13.9

560

3987

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

13.9

246

1457

N20.1

ICD-10 Finland

Calculus of ureter

1.8

13.9

215

1226

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.2

13.9

118

548

B01AF02

ATC

apixaban; oral

1.4

13.9

617

4471

N04BC05

ATC

pramipexole; oral

1.5

13.8

456

3125

N05AX08

ATC

risperidone; systemic

1.5

13.8

503

3514

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

3.6

13.8

122

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

13.8

145

730

49300

ICD-8 Finland

Asthma, bronchiale

2.0

13.8

146

737

R5599

NOMESCO Finland

Other rehabilitation service

1.8

13.8

195

1083

S01GX04

ATC

nedocromil; ophthalmic

2.1

13.7

129

623

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.0

13.7

146

738

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

13.7

1014

7945

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.1

13.7

133

650

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

1.8

13.7

215

1231

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.1

13.6

121

572

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.0

13.6

141

706

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.1

13.6

133

652

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

2.9

13.6

220

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

13.6

458

3153

N02CC06

ATC

eletriptan; oral

1.6

13.6

310

1960

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

13.6

472

3269

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

13.6

509

3577

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.3

13.6

100

438

W55

ICD-10 Finland

Bitten or struck by other mammals

1.7

13.5

268

1635

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

2.7

13.5

259

R03AA01

ATC

epinephrine; inhalant

14.7

13.5

H60.3

ICD-10 Finland

Other infective otitis externa

1.9

13.5

170

909

-50

ICPC

Medication/prescr/renewal

1.7

13.5

258

1559

DHB50

NOMESCO Finland

Turbinoplasty

1.8

13.5

188

1038

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.2

13.5

112

515

J02AC02

ATC

itraconazole; systemic

1.3

13.5

1260

10174

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

3.3

13.5

153

T68

ICD-10 Finland

Hypothermia

34.1

13.5

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

13.5

411

2772

K07.68

ICD-10 Finland

Other disorders of the jaw joint

2.6

13.5

294

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

2.9

13.5

221

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

13.4

368

2426

SAA04

NOMESCO Finland

Special examination of mouth

1.5

13.4

420

2850

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.1

13.4

119

563

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.6

13.4

278

K92.1

ICD-10 Finland

Melaena

1.6

13.3

281

1742

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

13.3

793

6021

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

13.3

158

829

C09AA04

ATC

perindopril; oral

1.7

13.3

257

1558

C05AA08

ATC

fluocortolone; rectal, topical

1.3

13.3

882

6804

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

13.3

281

1743

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.8

13.3

200

1131

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.8

13.3

180

986

WX882

NOMESCO Finland

High dependency care

1.8

13.3

188

1044

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

13.3

357

2344

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

13.3

171

922

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.9

13.2

173

937

K11.2

ICD-10 Finland

Sialoadenitis

1.7

13.2

240

1431

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

2.0

13.2

142

720

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

13.2

123

592

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.2

13.2

110

507

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

2.6

13.2

274

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.0

13.1

130

641

G83.4

ICD-10 Finland

Cauda equina syndrome

3.6

13.1

117

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

13.1

935

7290

C09BA02

ATC

enalapril and diuretics; systemic

1.5

13.1

388

2603

XKD00

NOMESCO Finland

Uroflowmetry

1.4

13.1

713

5343

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.9

13.1

159

842

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

2.8

13.0

225

C09CA01

ATC

losartan; oral

1.2

13.0

1493

12343

SPAT1324

SPAT

Screening procedure

0.8

13.0

1009

12664

G24.9

ICD-10 Finland

Dystonia, unspecified

3.8

13.0

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.3

13.0

847

6517

A69.2

ICD-10 Finland

Lyme disease

1.5

13.0

382

2557

K07.61

ICD-10 Finland

Cracking jaw joint

1.8

13.0

175

958

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

13.0

550

3953

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

13.0

397

2681

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.4

12.9

547

3928

R07.1

ICD-10 Finland

Chest pain on breathing

2.1

12.9

117

557

J03

ICD-10 Finland

Acute tonsillitis

1.7

12.9

248

1501

D84.19

ICD-10 Finland

Unspecified defect in the complement system

28.4

12.9

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

12.9

655

4850

L04AA01

ATC

[U] ciclosporin

2.3

12.9

422

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

12.9

159

845

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

12.9

413

2814

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

12.9

165

888

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

12.9

457

3177

SPAT1229

SPAT

Assessment of need for aid

1.5

12.9

421

2881

R07.2

ICD-10 Finland

Precordial pain

2.0

12.9

132

659

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.6

12.8

278

IER01

NOMESCO Finland

Psychoeducation, group

2.6

12.8

278

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

12.8

415

2835

L30.4

ICD-10 Finland

Erythema intertrigo

2.3

12.8

424

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

2.5

12.8

308

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

12.8

279

1746

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.0

12.7

133

668

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.0

12.7

143

737

N05AA02

ATC

levomepromazine; systemic

1.7

12.7

239

1439

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

12.7

120

581

R04.0

ICD-10 Finland

Epistaxis

1.5

12.7

414

2832

M01AH02

ATC

rofecoxib; oral

1.4

12.7

726

5481

A06AC51

ATC

ispaghula, combinations; oral

1.6

12.7

316

2041

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.2

12.6

439

S01GX05

ATC

lodoxamide; ophthalmic

2.2

12.6

103

471

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

209

29.25

314.09

1.0

0.30

0.04

u/ml

1.97

123

(3019420) Tryptase [Mass/volume] in Serum or Plasma

736

357

22.27

307.65

1.5

7.78

7.30

ug/l

0.20

631

325

(3005322) IgE [Units/volume] in Serum or Plasma

1763

5512

3.70

307.65

1.5

1.3

398.85

217.10

u/ml

4.92

1696

5080

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1063

2386

4.89

307.65

1.7

1.8

0.24

0.23

g/l

1.40

966

2272

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

647

187

37.07

307.65

1.3

1.2

111.77

111.30

0.08

592

162

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

663

212

33.56

307.65

1.3

1.2

0.31

0.30

g/l

1.28

513

171

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

320

51.72

307.65

1.0

0.46

0.03

u/ml

1.79

191

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

328

165

20.56

307.65

1.2

1.1

11.27

9.62

u/ml

0.13

243

123

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1064

2465

4.74

307.65

1.7

1.8

1.20

1.18

g/l

1.60

973

2350

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

197

24.82

279.50

1.1

1.0

5.28

0.50

u/ml

0.96

113

(3012494) Peanut IgE Ab [Units/volume] in Serum

304

291

10.76

277.92

1.1

16.23

14.17

u/ml

0.06

225

164

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

205

21.81

276.34

1.1

4.38

2.86

u/ml

0.38

158

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

191

24.97

271.65

1.1

1.0

0.74

0.18

u/ml

1.09

110

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

183

26.26

265.15

1.1

1.0

0.89

0.13

u/ml

1.87

106

(3022096) Basophils/100 leukocytes in Blood

5224

35249

2.08

254.95

6.9

6.2

0.65

0.68

3.11

4945

32932

(3011841) English Walnut IgE Ab [Units/volume] in Serum

194

20.19

253.15

1.1

6.81

4.74

u/ml

0.25

150

(3006504) Eosinophils/100 leukocytes in Blood

5338

36493

2.06

249.01

6.9

6.2

2.97

2.83

3.67

5060

34226

(3019069) Monocytes/100 leukocytes in Blood

5353

36700

2.06

246.92

7.1

6.5

8.16

8.32

3.74

5094

34490

(3013115) Eosinophils [#/volume] in Blood

5725

40361

2.06

242.70

7.0

6.3

0.21

0.19

e9/l

8.74

5131

35694

(3006315) Basophils [#/volume] in Blood

5575

38980

2.05

241.16

6.8

6.0

0.04

e9/l

0.79

4913

33934

(3001604) Monocytes [#/volume] in Blood

5564

38897

2.05

240.51

6.8

6.0

0.57

0.56

e9/l

0.87

4907

33913

(3002030) Lymphocytes/100 leukocytes in Blood

5467

38015

2.04

239.42

7.0

6.2

28.59

29.09

2.89

5215

35826

(3018010) Neutrophils/100 leukocytes in Blood

5394

37489

2.02

234.56

6.7

6.0

56.88

56.42

2.25

5136

35307

(3019198) Lymphocytes [#/volume] in Blood

5674

40274

2.02

230.90

6.9

6.0

1.98

1.97

e9/l

0.41

5138

35923

(3013650) Neutrophils [#/volume] in Blood by Automated count

6119

44737

2.04

227.53

9.5

9.0

4.22

3.99

e9/l

10.31

5412

39174

(40760892) CBC W Ordered Manual Differential panel - Blood

5268

36658

1.99

224.12

7.2

6.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

149

23.64

207.72

1.0

1.02

3.15

u/ml

0.65

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

132

26.23

191.34

1.0

2.18

2.51

u/ml

0.05

103

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

118

36.20

189.22

1.0

0.85

0.16

u/ml

1.35

109

(3027231) Wheat IgE Ab [Units/volume] in Serum

203

191

10.84

187.55

1.2

1.1

9.79

2.44

u/ml

0.71

164

171

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5134

37147

1.84

175.68

6.4

5.9

10.48

11.03

umol/l

2.17

4893

35108

(3016031) Almond IgE Ab [Units/volume] in Serum

128

21.98

173.42

1.1

0.82

1.27

u/ml

0.41

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

133

19.82

172.44

1.1

—

(3021589) Normoblasts [#/volume] in Blood

4850

34667

1.82

170.94

10.8

9.0

0.00

e9/l

2.07

3993

28354

(3002582) Erythrocytes [#/volume] in Urine

3350

21486

1.87

167.15

3.7

3.1

55.71

81.13

e6/l

0.45

2648

16203

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

116

25.52

166.50

1.0

17.15

18.97

u/ml

0.08

(3013707) Erythrocyte sedimentation rate by Westergren method

7070

57032

1.95

166.21

4.9

3.9

11.72

10.83

mm/h

6.53

6653

53180

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2802

16992

1.92

166.13

2.1

1.8

0.90

1.10

mg/l

3.90

2064

12684

(3013826) Glucose [Moles/volume] in Serum or Plasma

5642

42593

1.80

161.84

5.7

4.4

6.53

6.52

mmol/l

0.17

5356

39183

(3030467) Casts [#/volume] in Urine by Automated count

3106

19740

1.85

157.43

3.7

3.0

0.31

0.38

e6/l

1.31

2418

14765

(3018095) Leukocytes [#/volume] in Urine

3841

26048

1.80

157.15

4.4

3.5

89.13

88.69

e6/l

0.01

2793

17646

(36304419) Bacteria [Presence] in Urine

3073

19496

1.85

156.43

3.6

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7003

56867

1.89

153.92

8.7

7.1

76.27

76.76

u/l

0.41

6692

53699

(3023368) Bacteria identified in Blood by Culture

2791

17387

1.86

149.19

4.9

4.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4251

30081

1.75

147.20

12.6

11.8

1.15

1.19

inr

2.98

1442

9166

(40758558) Short blood count panel - Blood

3015

19313

1.82

146.78

6.9

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

112

18.57

141.04

1.1

1.0

7.49

7.83

u/ml

0.04

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4706

34644

1.71

138.18

7.7

6.5

1.22

mmol/l

0.16

4075

29503

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3077

20118

1.78

138.05

2.5

2.1

165.88

206.04

u/l

1.03

2921

18933

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

115

16.62

137.26

1.4

12.68

2.61

u/ml

1.01

101

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4339

31330

1.71

136.10

7.0

5.9

1.21

1.22

mmol/l

1.09

4005

28719

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

41.35

136.01

1.0

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6611

53649

1.77

134.31

5.3

4.1

—

(3026782) Osmolality of Urine

2317

14004

1.87

133.91

3.3

2.8

528.93

537.74

mosm/kgh2o

0.99

2028

11974

(3003888) Timothy IgE Ab [Units/volume] in Serum

576

1914

3.14

133.27

1.1

5.03

5.71

u/ml

0.49

413

1031

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

251

451

5.69

132.81

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

284

580

5.02

130.30

1.2

1.3

4.16

1.90

u/ml

2.08

220

306

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3573

24683

1.72

130.10

4.1

3.2

26.50

66.09

ng/l

1.14

2113

14578

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8818

79218

2.67

129.98

19.0

12.1

19.65

21.52

mg/l

7.27

7488

61420

(3031040) Bacteria [#/volume] in Urine by Automated count

6341

51272

1.72

125.77

5.5

4.1

438.43

1432.37

e6/l

2.98

601

(3033658) Prothrombin time (PT) actual/Normal

2827

18458

1.76

124.81

4.7

3.9

94.17

93.07

1.59

2761

17964

(3010726) Horse dander IgE Ab [Units/volume] in Serum

543

1818

3.11

123.88

1.1

3.22

1.92

u/ml

1.77

384

939

(3000850) Epithelial cells [#/volume] in Urine

2380

14842

1.81

122.57

3.0

2.5

7.00

6.57

e6/l

0.66

2153

13221

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3310

22685

1.71

122.13

3.0

2.5

54.81

62.34

u/l

1.38

3066

20995

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

597

2139

2.91

120.75

1.2

1.1

2.87

2.13

u/ml

0.87

412

1094

(3037522) Nuclear Ab [Titer] in Serum

1915

11308

1.87

116.99

1.5

1.4

555.10

559.15

titre

0.03

367

2316

(3008401) Mugwort IgE Ab [Units/volume] in Serum

530

1827

3.01

114.80

1.1

1.38

1.12

u/ml

0.39

360

802

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2057

12511

1.82

113.87

4.2

3.4

208.11

504.39

ng/l

2.52

1359

8598

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1876

11165

1.85

111.10

3.1

2.8

3.83

3.28

e6/l

1.18

1014

5902

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1805

10633

1.86

110.37

2.1

1.8

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

17.76

108.56

1.1

1.0

1.74

0.30

u/ml

1.73

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8145

71981

1.95

106.97

16.1

11.0

88.28

87.01

ml/min/173m2

5.68

7092

58768

(3019550) Sodium [Moles/volume] in Serum or Plasma

8648

78109

2.25

106.78

19.6

13.2

139.51

139.63

mmol/l

4.89

8512

76061

(3024561) Albumin [Mass/volume] in Serum or Plasma

4072

30186

1.61

106.19

5.3

4.8

36.07

36.15

g/l

0.39

3836

28122

(3023103) Potassium [Moles/volume] in Serum or Plasma

8659

78349

2.24

104.73

19.8

13.3

3.92

3.94

mmol/l

14.07

8507

76106

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

13.95

102.23

1.1

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

252

579

4.44

100.11

1.1

1.84

1.05

u/ml

0.32

151

158

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1263

6837

1.98

98.80

2.6

2.4

33.16

43.64

u/l

0.84

1071

5850

(3018418) pH of Serum or Plasma

2935

20371

1.64

98.10

4.5

3.9

7.40

0.18

583

3972

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3787

28005

1.59

97.03

2.1

1.9

95.27

97.38

pmol/l

2.02

2075

14737

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1923

11959

1.76

96.70

3.0

2.6

1.39

1.15

e6/l

0.37

1070

6661

(3026008) Bacteria identified in Urine by Culture

3156

22435

1.61

95.00

3.3

2.8

—

(40768797) Stomach Pathology biopsy report

1658

9953

1.81

93.71

1.3

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3479

25374

1.59

93.63

3.3

3.2

30.79

32.69

u/l

0.64

3288

24140

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7272

62886

1.68

93.18

4.7

4.1

14.53

14.58

pmol/l

0.94

6758

57877

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1696

10319

1.78

91.37

2.3

2.4

29.85

29.64

0.68

1649

9996

(3020874) Milk IgE Ab [Units/volume] in Serum

261

661

4.03

91.16

1.3

1.1

10.46

0.82

u/ml

2.24

178

233

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1270

7125

1.90

88.68

2.0

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

257

657

3.99

88.61

1.2

1.1

14.72

2.67

u/ml

1.23

161

185

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2767

19385

1.60

86.77

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1269

7170

1.89

86.55

2.0

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8163

73313

1.83

86.23

5.7

4.7

1.78

1.97

mu/l

2.90

7689

68283

(3007164) IgA [Mass/volume] in Serum or Plasma

2518

17277

1.62

85.89

1.6

1.4

2.24

g/l

0.00

1494

10744

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1740

11023

1.71

80.10

4.0

3.7

0.82

mmol/l

0.64

1640

10369

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2108

14161

1.63

76.99

1.4

1.3

26.98

29.08

iu/ml

0.28

594

4513

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2786

20017

1.56

76.28

1.4

1.3

1.60

1.63

u/ml

0.04

728

5506

(3012544) pH of Venous blood

1098

6175

1.88

75.31

5.0

4.5

7.37

—

(3000492) Spirometry study

1306

7750

1.79

75.27

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1387

8383

1.77

75.07

2.9

6.46

7.34

umol/l

1.12

1177

7190

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2014

13463

1.63

74.72

1.3

8.81

10.86

u/ml

0.76

719

5502

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1070

5986

1.89

74.55

5.1

4.5

5.81

5.82

kpa

0.19

1042

5812

(3007853) Bacteria identified in Skin by Aerobe culture

1438

8801

1.75

74.43

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

4767

38445

1.48

74.41

5.7

4.6

0.00

estimate

0.36

1083

7490

(3002032) Base excess in Venous blood by calculation

1065

5964

1.89

73.94

5.1

4.5

1.77

1.81

mmol/l

0.10

917

5013

(3009261) Glucose [Presence] in Urine by Test strip

4792

38777

1.48

72.94

4.2

3.4

0.00

estimate

0.07

1049

7309

(3014111) Lactate [Moles/volume] in Serum or Plasma

1012

5598

1.90

72.92

7.8

7.2

1.36

1.32

mmol/l

0.51

993

5468

(3035350) Ketones [Presence] in Urine by Test strip

4751

38417

1.48

72.35

4.2

3.4

0.00

estimate

0.46

1123

7771

(3015377) Calcium [Moles/volume] in Serum or Plasma

3197

23924

1.51

71.36

3.3

3.2

2.35

mmol/l

0.47

2848

21256

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2335

16324

1.57

71.24

3.0

2.9

1184.09

1162.93

ng/l

0.08

1956

13719

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8861

82655

2.14

71.03

19.8

13.5

73.40

72.41

umol/l

2.01

8861

82631

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6282

53867

1.49

69.84

3.7

2.9

45.37

41.24

u/l

3.23

5936

50813

(3042936) Bacteria identified in Isolate by Culture

1552

9858

1.69

69.74

2.1

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1696

11025

1.66

69.72

2.7

2.4

13.03

13.66

umol/l

2.96

1566

10346

(3000991) Gas panel - Venous blood

993

5549

1.88

69.16

9.7

8.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1237

7412

1.77

68.51

2.4

2.2

355.73

372.43

nmol/l

2.03

1147

6820

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4069

32149

1.47

68.34

2.6

2.3

74.12

75.64

nmol/l

2.88

3720

29446

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4665

37841

1.46

68.28

3.4

2.9

100.23

98.19

ug/l

0.23

4364

35509

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1567

10088

1.66

66.58

2.7

2.4

2.42

2.40

g/l

0.66

1422

9372

(3048689) Calprotectin [Mass/mass] in Stool

1692

11123

1.63

66.15

2.5

2.4

120.29

120.72

ug/g

0.02

1327

8769

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2553

18498

1.52

65.18

2.5

2.2

2.72

2.85

mg/l

2.17

2208

15883

(3014133) Dog dander IgE Ab [Units/volume] in Serum

390

1539

2.60

64.97

1.1

6.88

4.64

u/ml

1.23

262

753

(3015736) pH of Urine

3932

31084

1.45

64.65

3.7

3.1

5.95

5.94

0.08

342

2828

(3026493) Urate [Moles/volume] in Serum or Plasma

2504

18125

1.52

64.01

2.7

2.5

2827.11

3737.03

umol/l

0.72

2208

16128

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1458

9299

1.67

63.99

2.8

2.5

22.10

23.16

2.19

1268

8029

(3021960) Folate [Moles/volume] in Serum or Plasma

2188

15393

1.55

63.76

1.6

1.5

19.69

20.61

nmol/l

2.36

1890

13300

(3044640) Blood type and Crossmatch panel - Blood

3164

24076

1.47

63.02

2.6

2.2

—

(3002385) Erythrocyte distribution width [Ratio]

7711

69687

1.58

61.57

21.3

14.6

14.63

14.68

0.19

7639

68480

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

888

4962

1.87

61.53

1.6

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

364

1431

2.61

61.09

1.1

6.35

5.82

u/ml

0.19

228

611

(3013512) EKG study

2583

19032

1.49

59.82

4.0

3.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

876

4957

1.85

58.18

4.5

4.1

4.74

4.72

kpa

0.12

849

4803

(3044889) 12 lead EKG panel

5837

50202

1.42

57.25

3.9

3.3

—

(4200892) Spirometry reversibility

885

5070

1.82

56.41

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6752

59730

1.46

56.11

4.1

3.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

657

3431

1.98

55.59

5.3

24.25

24.05

mmol/l

0.83

647

3375

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

317

1250

2.59

52.86

1.1

0.76

0.28

u/ml

1.01

157

350

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

784

4429

1.84

52.14

9.0

8.2

24.86

24.73

mmol/l

0.52

778

4404

(3005719) IgG [Mass/volume] in Serum or Plasma

989

5994

1.73

51.74

2.8

2.7

10.21

10.38

g/l

0.72

912

5522

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

112

7.01

51.54

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

685

3729

1.90

51.15

1.8

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1153

7333

1.65

50.22

3.8

4.4

225.06

242.23

u/l

5.36

1091

6932

(3019309) Folate [Moles/volume] in Red Blood Cells

1674

11689

1.53

48.73

1.9

1.7

1091.73

1173.81

nmol/l

3.30

1293

8957

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8810

83285

1.84

48.70

12.5

9.5

26.22

25.82

u/l

1.18

8622

80603

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2429

18298

1.44

48.15

2.5

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

707

4029

1.82

45.52

1.6

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

916

5629

1.69

45.26

2.4

2.3

20.44

24.20

au/ml

0.52

491

(40768804) Tissue Pathology biopsy report

3844

31563

1.37

45.15

2.1

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4398

36910

1.36

44.76

2.8

2.5

—

(3022145) Colonoscopy Study observation

1230

8184

1.58

44.10

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7393

67504

1.44

43.89

5.8

5.0

39.05

38.66

mmol/mol

3.13

6922

63108

(3000494) Fungus identified in Specimen by Culture

1287

8665

1.56

43.80

1.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

17.20

43.64

1.1

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

778

4641

1.74

42.75

2.0

1.8

1.43

1.32

g/l

0.59

716

4289

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1307

8876

1.55

42.71

7.2

6.2

1.07

1.06

mmol/l

0.26

1250

8304

(3027945) Reticulocytes/100 erythrocytes in Blood

1084

7062

1.60

42.40

2.7

2.9

1.75

1.74

0.14

961

6284

(40761511) CBC panel - Blood by Automated count

8767

83176

1.74

42.10

16.0

11.3

—

(3017181) Myelocytes/100 leukocytes in Blood

969

6163

1.64

41.77

4.4

4.2

0.80

0.93

0.67

325

1934

(3021440) Promyelocytes/100 leukocytes in Blood

934

5894

1.65

41.52

4.5

4.3

0.08

0.13

1.15

289

1667

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

844

5191

1.69

41.42

1.3

42.77

51.22

au/ml

0.37

258

(3009445) Proteinase 3 Ab [Units/volume] in Serum

546

2957

1.90

41.25

1.4

1.6

8.35

12.07

u/ml

—

(3002179) Metamyelocytes/100 leukocytes in Blood

903

5673

1.65

40.82

4.2

4.0

0.48

0.67

2.58

294

1691

(3015171) Extractable nuclear Ab [Units/volume] in Serum

595

3330

1.84

40.53

1.3

1.64

1.12

u/ml

0.26

285

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

121

317

3.85

40.44

1.1

16.96

12.82

u/ml

0.67

193

(3025159) Blasts/100 leukocytes in Blood

894

5636

1.65

39.83

4.4

4.3

0.02

0.31

1.89

245

1416

(3017958) Strawberry IgE Ab [Units/volume] in Serum

14.63

39.05

1.0

0.27

0.08

u/ml

0.47

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

361

1721

2.14

38.98

2.1

0.01

0.02

g/l

0.50

344

1594

(3052851) Hemolysis interference index of Serum or Plasma

416

2093

2.03

38.91

3.0

2.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

2263

1.98

38.01

2.1

2.2

7.28

7.37

g/l

0.53

413

2070

(3009343) pH of Capillary blood

723

4364

1.71

37.94

5.0

4.3

7.41

0.15

108

529

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1677

12253

1.45

37.85

2.9

2.8

2.44

mmol/l

0.17

1463

10691

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

2260

1.98

37.82

2.1

2.2

—

(3003396) Base excess in Arterial blood by calculation

1046

6933

1.57

37.77

8.3

7.3

0.84

0.94

mmol/l

0.31

851

5434

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

729

4416

1.71

37.75

5.1

4.3

5.18

5.13

kpa

1.26

700

4215

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

704

4228

1.72

37.62

5.0

4.3

1.83

1.57

mmol/l

1.19

530

3087

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

2141

2.00

37.53

2.1

2.2

2.92

g/l

0.04

394

1951

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

436

2260

1.97

37.49

2.1

2.2

3.81

3.63

g/l

1.28

410

2070

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

334

1569

2.17

37.44

2.2

0.00

g/l

-0.00

322

1465

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

337

1590

2.16

37.36

2.1

2.2

0.00

g/l

0.43

321

1469

(3013139) Helicobacter pylori Ag [Presence] in Stool

842

5316

1.64

37.19

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

581

3317

1.80

37.02

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

387

1937

2.04

36.71

2.1

2.3

0.72

0.82

g/l

0.26

355

1696

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

409

2092

2.00

36.52

2.1

2.2

10.15

10.21

g/l

0.11

383

1890

(3020630) Protein [Mass/volume] in Serum or Plasma

797

4985

1.65

36.51

2.6

2.5

67.00

66.70

g/l

0.56

747

4594

(3003327) Ova and parasites identified in Stool by Light microscopy

541

3041

1.83

36.28

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2701

21526

1.36

36.27

3.8

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2296

17836

1.38

36.24

3.8

3.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

567

3239

1.80

36.04

10.6

9.5

24.32

24.23

mmol/l

0.24

554

3154

(3009508) Creatinine [Moles/volume] in Urine

2668

21242

1.36

36.00

3.5

3.2

7.67

7.66

mmol/l

0.05

2245

18295

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1014

6744

1.56

35.97

1.3

1.2

145.78

148.95

iu/ml

0.06

355

2607

(3027801) Oxygen [Partial pressure] in Arterial blood

1038

6945

1.56

35.85

8.3

7.3

12.29

12.88

kpa

2.82

994

6617

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1038

6948

1.55

35.78

8.3

7.3

5.08

5.07

kpa

0.04

994

6620

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

358

1759

2.08

35.71

2.1

38.37

38.19

g/l

0.24

333

1567

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

625

3684

1.75

35.67

2.0

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

312

1455

2.18

35.63

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

312

1455

2.18

35.63

1.4

1.3

—

(3016502) Oxygen saturation in Arterial blood

937

6143

1.58

35.35

8.7

7.8

95.38

95.97

1.62

908

5893

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7841

73090

1.43

35.29

4.6

4.0

5.86

5.77

mmol/l

7.06

7242

67544

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1938

14691

1.40

35.29

2.5

2.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

406

2101

1.97

35.07

2.5

2.4

228.68

560.39

ug/l

2.30

371

1951

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1773

13251

1.42

35.00

2.4

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

409

2126

1.97

34.87

1.4

1.3

10.99

9.19

u/ml

0.15

346

(3002173) Hemoglobin [Mass/volume] in Arterial blood

880

5704

1.60

34.82

9.0

8.1

123.33

121.80

g/l

1.38

860

5531

(3007456) Orange IgE Ab [Units/volume] in Serum

13.24

34.80

1.0

0.05

0.11

u/ml

0.46

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

51.45

34.40

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

661

4007

1.70

34.05

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

439

2363

1.90

33.73

1.5

1.6

205.25

326.54

titre

0.71

107

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

401

2096

1.95

33.64

1.4

1.3

5.38

5.95

u/ml

0.09

212

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

434

2331

1.90

33.57

1.4

1.3

28.63

40.23

u/ml

0.45

159

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

368

1873

2.00

33.33

1.4

1.5

20.10

13.30

iu/ml

0.35

(3025941) Bacteria identified in Stool by Culture

753

4749

1.64

33.29

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

9182

88948

2.10

33.09

26.7

18.0

40.06

40.39

1.79

8886

84158

(40767503) Oxygen content in Capillary blood by calculation

297

1403

2.15

32.85

3.2

2.4

16.64

16.56

0.13

153

720

(3007461) Platelets [#/volume] in Blood

9186

89039

2.09

32.43

26.6

18.0

263.30

258.83

e9/l

9.12

9062

86941

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

460

2552

1.84

32.15

2.0

1.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

7.09

32.15

1.1

1.0

2.08

0.18

u/ml

0.54

(3020779) Urea [Moles/volume] in Serum or Plasma

866

5701

1.57

31.96

9.1

8.1

8.59

8.75

mmol/l

0.28

834

5474

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

825

5377

1.59

31.79

2.7

2.2

8579.08

5990.44

u/l

0.92

298

2146

(3035941) MCH [Entitic mass]

9188

89107

2.08

31.72

26.4

17.9

30.09

30.12

1.24

9133

88022

(3026361) Erythrocytes [#/volume] in Blood

9189

89122

2.08

31.69

26.6

17.9

4.50

e12/l

0.68

9047

86841

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

220

932

2.39

31.55

1.2

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

389

2058

1.93

31.49

1.4

299.73

286.87

ug/g

0.53

194

1143

(3010813) Leukocytes [#/volume] in Blood

9189

89134

2.08

31.48

26.6

18.0

6.99

6.70

e9/l

24.33

9044

86804

(3000963) Hemoglobin [Mass/volume] in Blood

9190

89148

2.08

31.47

26.8

18.0

134.37

134.98

g/l

4.33

9138

88072

(3024731) MCV [Entitic volume]

9187

89112

2.07

31.40

26.5

17.9

90.40

90.36

0.34

9133

88026

(3023511) Choriogonadotropin [Units/volume] in Urine

491

2800

1.79

31.35

1.5

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

529

3084

1.76

31.32

1.6

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

605

3663

1.70

31.26

4.2

3.7

129.93

129.61

g/l

0.13

594

3574

(3014007) Fractional oxyhemoglobin in Arterial blood

623

3820

1.68

30.69

10.4

9.2

93.79

94.20

0.86

623

3805

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

562

3352

1.72

30.68

10.3

9.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1417

10417

1.42

30.24

2.0

1.7

1.46

1.39

3.00

1228

9305

(3023520) Reticulocytes [#/volume] in Blood

786

5128

1.58

30.10

2.7

2.8

70.15

70.28

e9/l

0.03

561

3801

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

232

1033

2.28

29.70

1.2

1.3

0.52

2.09

nmol/l

0.74

220

999

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

233

1042

2.27

29.52

1.2

1.3

0.21

0.29

nmol/l

—

(40768443) Skin Pathology biopsy report

540

3220

1.72

29.49

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

332

1702

1.99

29.47

1.3

7.08

4.15

u/ml

0.30

122

(3028271) Lactate [Moles/volume] in Capillary blood

233

1049

2.25

29.06

2.3

1.8

1.68

1.67

mmol/l

0.04

225

1022

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

356

1879

1.93

29.03

1.2

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

10.35

28.87

1.0

1.1

0.16

0.10

u/ml

0.20

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

33.76

28.65

1.0

0.15

0.03

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3512

29775

1.29

28.50

4.3

3.5

—

(36660697) Celiac disease serology panel - Serum

1029

7196

1.48

28.50

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1002

6991

1.48

28.05

3.8

3.1

—

(3027315) Oxygen [Partial pressure] in Blood

301

1521

2.01

27.84

4.2

8.87

8.79

kpa

0.29

296

1495

(3012501) Base excess in Blood by calculation

299

1512

2.01

27.60

4.2

4.1

2.02

2.44

mmol/l

2.42

190

996

(3013290) Carbon dioxide [Partial pressure] in Blood

299

1513

2.01

27.55

4.2

4.1

4.96

5.00

kpa

0.51

294

1488

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

9.20

27.35

1.0

1.1

0.17

0.11

u/ml

0.23

(3036489) Thrombin time

500

2981

1.72

27.31

2.3

2.6

20.87

21.45

1.49

443

2547

(3024891) Influenza virus A+B Ag [Presence] in Specimen

398

2221

1.83

27.29

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

410

2310

1.81

27.25

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2373

19202

1.31

27.11

4.2

3.9

19.43

9.60

mg/mmol

0.71

1483

12164

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

745

4923

1.56

26.90

2.6

2.3

4.69

7.19

ug/l

5.73

642

4281

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

523

3173

1.69

26.77

1.8

1.9

38.61

39.24

u/l

0.33

487

2866

(3010421) pH of Blood

333

1767

1.92

26.74

4.2

4.0

7.42

0.03

310

1624

(3021901) Oxygen saturation in Capillary blood

242

1145

2.14

26.71

3.5

2.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

312

1621

1.96

26.67

3.9

3.4

24.64

24.61

mmol/l

0.04

304

1586

(1616796) Gas panel - Central venous blood

298

1524

1.99

26.66

4.0

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

409

2323

1.80

26.46

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

832

5652

1.52

26.45

4.2

3.8

1.23

mmol/l

1.30

724

4941

(3017143) Hepatitis C virus Ab [Presence] in Serum

1478

11196

1.38

26.12

1.7

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

351

1912

1.87

26.01

3.1

2.6

—

(3012516) Albumin [Mass/volume] in Urine

2267

18353

1.31

25.54

3.6

3.3

338.52

410.34

mg/l

0.33

1466

11627

(3000330) Specific gravity of Urine by Test strip

544

3379

1.65

25.43

3.5

3.1

—

(3024928) Oxygen saturation in Venous blood

266

1337

2.02

25.00

3.3

4.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

302

1602

1.91

24.29

3.4

3.7

57.95

56.88

0.85

302

1602

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

395

2290

1.76

23.84

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

623

4079

1.56

23.37

1.7

1.6

333.15

318.19

mu/l

0.40

564

3664

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

481

2965

1.66

23.16

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

349

1974

1.80

22.92

2.5

2.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

302

1640

1.87

22.63

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

344

1945

1.80

22.62

1.4

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

800

5562

1.48

22.61

3.2

3.3

4.50

4.53

pmol/l

0.48

724

4982

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

326

1816

1.82

22.52

1.3

55.67

43.26

u/ml

0.65

188

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

429

2587

1.69

22.46

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

453

2774

1.66

22.38

1.8

1.54

1.48

g/l

0.68

396

2365

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8038

76435

1.34

22.29

4.8

4.3

2.79

2.83

mmol/l

2.31

7499

71458

(46235355) HIV 1 and 2 tests - Meaningful Use set

2479

20632

1.27

21.92

2.1

2.0

—

(40761536) Microorganisms panel - Urine sediment

951

6876

1.43

21.82

4.7

3.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

979

7120

1.42

21.73

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

252

1307

1.95

21.71

1.7

1.6

0.71

g/l

0.04

194

996

(3022806) Fractional oxyhemoglobin in Capillary blood

187

870

2.17

21.62

2.1

1.8

90.48

90.18

0.30

182

856

(3023420) DNA double strand Ab [Units/volume] in Serum

194

916

2.14

21.60

1.7

1.6

41.73

29.98

iu/ml

0.44

(44813793) Dust mix specific IgE antibody measurement

153

655

2.36

21.57

1.1

—

(3045414) Leukocytes [Presence] in Urine

535

3447

1.59

21.50

2.0

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2307

19070

1.28

21.49

1.7

1.6

1.45

1.36

mmol/l

4.23

1953

16306

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

401

2405

1.70

21.44

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

215

1059

2.05

21.42

1.7

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

335

1912

1.78

21.36

6.1

4.9

8.57

8.77

kpa

1.26

323

1864

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

318

2.98

21.20

1.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

910

6574

1.43

20.94

2.4

0.22

g/l

0.79

855

6163

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

324

1843

1.78

20.90

1.4

1.3

271.26

253.35

u/ml

0.51

202

1156

(3007700) Barley IgE Ab [Units/volume] in Serum

7.07

20.74

1.1

1.0

38.59

0.78

u/ml

0.48

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

706

4871

1.49

20.70

3.0

2.9

150.50

166.17

ng/l

0.53

627

4397

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

228

1162

1.99

20.68

1.7

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

398

2409

1.68

20.56

2.6

2.9

176.44

179.97

0.35

378

2281

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

728

5072

1.47

20.31

4.7

4.0

89.35

83.33

ng/l

0.92

629

4432

(3002256) Pathology report gross observation

1268

9736

1.35

20.13

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

337

1961

1.75

20.11

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1812

14634

1.29

20.07

1.8

1.6

20131153.19

31608325.80

pmol/l

0.48

1530

12364

(4062490) Immunoglobulin typing, IgG

178

838

2.15

20.00

1.6

1.3

—

(3008898) HLA-B27 [Presence]

524

3419

1.56

19.94

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

6.42

19.61

1.1

1.0

47.15

0.11

u/ml

0.50

(3027273) Bicarbonate [Moles/volume] in Venous blood

444

2801

1.61

19.50

4.5

3.3

25.13

25.25

mmol/l

0.37

434

2707

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

342

2024

1.72

19.22

1.8

2.0

10.89

10.82

mg/l

0.06

326

1893

(3017732) Neutrophils [#/volume] in Blood

775

5529

1.44

19.06

2.7

2.6

4.33

4.68

e9/l

1.05

631

4615

(3029937) Albumin [Presence] in Urine by Test strip

2427

20430

1.25

18.96

4.6

3.8

0.00

estimate

0.75

1055

7287

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7871

74976

1.30

18.94

4.3

3.9

1.44

1.49

mmol/l

28.25

7344

70200

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7614

72227

1.28

18.90

3.9

3.5

1.36

1.25

mmol/l

22.89

7056

67206

(3011985) Renin [Units/volume] in Plasma

195

976

2.02

18.65

1.5

1.6

63.49

62.40

mu/l

0.02

178

868

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

539

3598

1.53

18.50

1.1

41.81

3.38

u/ml

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

175

845

2.09

18.45

1.6

1.3

6.44

6.62

g/l

0.27

126

599

(3024139) IgG subclass 3 [Mass/volume] in Serum

175

845

2.09

18.45

1.6

1.3

0.33

0.40

g/l

2.83

125

595

(3028192) IgG subclass 2 [Mass/volume] in Serum

175

846

2.09

18.39

1.6

1.3

2.72

2.90

g/l

0.79

126

599

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

283

1610

1.78

18.29

1.8

1.7

—

(3023419) Bacteria identified in Sputum by Culture

182

898

2.05

18.12

2.4

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7909

75484

1.29

18.05

4.4

3.9

4.67

4.73

mmol/l

6.59

7426

70932

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

116

476

2.45

18.03

2.6

2.9

89.11

102.62

nmol/l

0.30

111

471

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

323

1917

1.71

17.99

3.6

4.6

0.34

u/ml

0.04

177

1071

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

931

2.02

17.81

1.8

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

205

1062

1.95

17.80

1.3

42.29

58.41

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

331

2.74

17.49

1.2

1.1

3.22

4.09

iu/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

322

1928

1.69

17.37

2.5

2.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1170

9086

1.33

17.02

2.0

1.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

336

2053

1.66

16.79

1.3

1.5

487.70

488.79

mg/l

0.01

324

1947

(3019225) pH of Specimen

895

6690

1.37

16.73

4.2

4.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

407

2611

1.58

16.69

2.7

3.3

94.42

93.21

0.51

391

2504

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

179

907

1.99

16.59

1.4

862.47

399.71

pmol/l

0.40

161

794

(3021788) Differential panel - Synovial fluid

220

1198

1.86

16.45

1.6

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

280

1639

1.73

16.42

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

187

970

1.95

16.21

1.4

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

134

615

2.20

16.14

1.5

1.34

1.29

promille

0.14

470

(3020961) Endomysium IgA Ab [Titer] in Serum

633

4490

1.44

16.03

1.1

110.00

242.71

titre

1.14

118

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

688

4956

1.42

16.00

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

326

2002

1.65

15.99

1.3

1.2

—

(3022313) Gas panel - Capillary blood

481

3235

1.51

15.95

5.4

4.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

183

951

1.94

15.79

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

463

3101

1.52

15.66

4.2

2.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

181

940

1.94

15.65

1.4

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

159

789

2.03

15.65

1.8

1.7

—

(3022621) pH of Urine by Test strip

676

4874

1.42

15.63

2.9

2.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

181

943

1.94

15.51

1.4

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

137

645

2.14

15.50

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

137

645

2.14

15.50

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

137

646

2.14

15.44

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

359

2278

1.60

15.44

2.2

2.0

1.49

2.21

ug/l

1.00

310

2021

(3005988) Vibrio sp identified in Specimen by Organism specific culture

181

945

1.93

15.42

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

299

1815

1.67

15.35

1.2

1.5

3.59

3.66

mmol/l

0.87

284

1697

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

379

2441

1.58

15.30

2.9

3.3

3.53

g/l

0.01

356

2305

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1354

10875

1.29

15.24

1.6

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

130

604

2.17

15.22

1.1

1.2

200.00

203.90

titre

0.02

123

(3030981) Hyaline casts [#/volume] in Urine by Automated count

500

3426

1.49

15.15

2.8

2.6

0.22

0.25

e6/l

0.37

479

3315

(3004616) Nuclear Ab [Presence] in Serum

180

944

1.92

15.14

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

652

2.12

15.09

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

652

2.12

15.09

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

137

653

2.11

15.03

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

196

1061

1.87

14.97

3.2

3.3

1.13

1.50

0.84

167

963

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

112

493

2.29

14.95

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

509

3510

1.48

14.94

2.6

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

180

954

1.90

14.68

1.4

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

282

1707

1.67

14.66

1.3

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

434

2917

1.51

14.45

5.7

4.7

25.03

24.60

mmol/l

2.79

409

2747

(3017354) Segmented neutrophils/100 leukocytes in Blood

133

638

2.10

14.37

2.9

3.2

58.33

56.64

0.41

108

550

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

393

2591

1.54

14.32

1.7

1.6

2.01

8.93

iu/ml

0.51

535

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

228

1312

1.76

14.26

1.3

1.2

3.13

4.09

u/ml

0.80

100

553

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

120

555

2.18

14.24

1.3

1.2

12.70

12.84

u/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

332

2.54

14.23

3.6

2.2

201.90

160.21

umol/l

0.40

174

(3047007) Chlamydophila sp Ab [Presence] in Serum

231

1335

1.75

14.23

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

668

4885

1.40

14.23

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2009

17022

1.23

14.09

1.8

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

279

1705

1.66

14.00

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

232

1350

1.74

13.96

1.3

1.2

3.40

3.70

u/ml

0.10

454

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

283

1740

1.65

13.87

2.9

3.2

32.83

51.64

mg/l

1.47

226

1408

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

297

1849

1.63

13.85

1.5

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

122

576

2.13

13.76

1.3

1.2

67.14

65.69

u/ml

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

276

1690

1.65

13.75

2.9

3.2

1.29

1.95

ratio

1.15

155

(3034860) Kappa light chains.free [Mass/volume] in Serum

282

1741

1.64

13.60

2.9

3.2

53.92

82.30

mg/l

0.41

225

1408

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

122

580

2.12

13.52

1.3

1.2

60.11

41.06

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

217

1257

1.74

13.29

1.8

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

240

1435

1.69

13.11

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

926

7209

1.32

13.09

1.9

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

256

1560

1.66

13.01

6.1

6.0

749.29

637.16

iu/ml

0.08

194

(3023183) Ammonium ion [Moles/volume] in Plasma

233

1385

1.70

13.01

2.5

3.0

32.45

35.07

umol/l

1.02

216

1275

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

225

1326

1.71

12.97

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

420

2873

1.48

12.87

2.2

1.9

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

119

574

2.09

12.73

3.5

4.1

—

(3036180) Methadone [Presence] in Urine

104

477

2.19

12.65

2.5

3.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

250

1531

1.65

12.48

2.8

2.1

129.73

130.05

g/l

0.07

187

1118

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

287

1819

1.60

12.47

1.3

1.7

3014.89

3113.72

e6/l

0.01

236

1467

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

290

1849

1.59

12.29

1.5

1.4

8.26

22.39

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

489

3475

1.43

12.28

2.5

2.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

103

477

2.17

12.25

1.7

1.6

19.68

24.07

umol/l

0.97

453

(3033705) Calcium.ionized [Moles/volume] in Venous blood

129

652

1.99

12.17

3.0

2.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

146

770

1.91

12.17

2.8

3.1

5.44

11.91

nmol/l

0.43

138

746

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

427

2.24

12.16

1.1

10.46

9.57

u/ml

0.08

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

100

460

2.19

12.10

1.3

1.5

4.98

6.22

u/l

1.57

390

(3016879) Cocaine [Presence] in Urine

575

4215

1.39

12.08

2.7

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

922

1.83

12.07

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

285

1819

1.58

12.04

1.3

1.6

18.84

25.29

e6/l

0.42

222

1391

(3028300) Cannabinoids [Presence] in Urine

623

4631

1.37

12.01

2.6

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

364

2460

1.50

11.86

5.1

5.2

0.89

0.90

0.23

343

2287

(3027008) Opiates [Presence] in Urine

620

4619

1.37

11.79

2.6

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

616

4588

1.37

11.73

2.6

2.0

—

(3042517) Benzodiazepines panel - Urine

112

3.49

11.65

2.7

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

269

1715

1.59

11.44

2.2

2.4

7.81

6.58

umol/l

0.30

193

1271

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

211

1266

1.68

11.43

1.1

120.76

116.25

1.18

187

1144

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

220

1337

1.66

11.36

1.1

—

(3044941) Cell count panel - Synovial fluid

179

1030

1.75

11.29

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

249

1567

1.60

11.19

1.7

1.6

16177.60

11195.35

e6/l

0.63

161

1132

(3002079) Sodium [Moles/time] in 24 hour Urine

347

2.32

11.17

1.2

1.3

169.59

151.58

mmol/24h

1.25

347

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

205

1230

1.68

11.12

1.5

1.6

—

(1002224) Polysomnography panel

474

3415

1.41

11.04

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

162

915

1.78

10.91

1.2

1.1

95.03

94.66

0.06

149

859

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

202

1214

1.68

10.90

3.9

3.5

346.73

1199.01

u/ml

1.16

(3003338) MCHC [Mass/volume]

7290

69873

1.19

10.88

22.4

15.3

332.19

332.58

g/l

3.25

7258

69354

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

267

1720

1.57

10.88

1.6

1.5

116.78

111.14

u/ml

0.20

339

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

149

824

1.82

10.76

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

361

2486

1.47

10.75

5.0

5.1

1.73

1.67

0.46

340

2306

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

214

1311

1.65

10.73

1.1

—

(3027944) Amphetamines [Presence] in Urine

605

4557

1.35

10.73

2.5

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

115

585

1.98

10.71

1.6

1.3

1.74

1.45

nmol/l

1.77

102

528

(3049717) Cytology report of Urine Cyto stain

296

1959

1.53

10.69

2.6

2.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

114

580

1.98

10.62

1.7

2.5

—

(3037756) Immunofixation for Serum or Plasma

187

1110

1.70

10.58

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

710

5492

1.32

10.49

1.4

23.29

25.88

iu/l

1.37

595

4687

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

185

1098

1.70

10.48

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

254

1634

1.57

10.43

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

194

1168

1.67

10.42

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

194

1168

1.67

10.42

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

265

1722

1.55

10.41

1.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

214

1324

1.63

10.34

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

189

1135

1.68

10.26

1.2

—

(3019060) Gas panel - Arterial blood

524

3890

1.37

10.21

4.5

4.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

1186

1.66

10.09

1.7

1.5

—

(3011648) Oxygen content in Venous blood

108

550

1.97

10.06

2.4

4.9

10.93

11.22

0.28

108

550

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

218

1372

1.60

9.85

3.5

3.0

—

(3016018) Differential panel - Cerebral spinal fluid

158

918

1.73

9.70

1.2

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

371

2622

1.43

9.66

2.0

1.8

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

141

799

1.78

9.45

1.9

2.6

23.64

19.79

nmol/l

2.81

135

763

(3036071) Salmonella sp Ab [Titer] in Serum

293

2.30

9.25

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

316

2187

1.46

9.22

1.8

1.9

3.00

8.08

iu/l

0.79

112

857

(3045142) Bone marrow Pathology biopsy report

129

718

1.81

9.19

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

288

2.30

9.17

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

106

555

1.92

9.15

3.2

2.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

130

728

1.80

9.09

1.9

2.5

43.04

39.57

1.97

125

720

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

131

740

1.78

8.90

1.3

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

125

697

1.80

8.87

3.5

3.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.91

8.85

1.3

1.5

130.80

123.20

ug/l

0.09

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

164

991

1.67

8.76

1.6

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

227

1486

1.54

8.70

1.2

1.1

8.99

10.60

au/ml

0.19

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

129

734

1.77

8.57

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

313

2199

1.44

8.47

1.3

124.52

124.41

titre

0.00

202

(3009466) Valproate [Moles/volume] in Serum or Plasma

174

1079

1.62

8.42

5.2

5.3

361.72

371.16

umol/l

0.41

145

936

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

103

550

1.88

8.41

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

103

550

1.88

8.41

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

103

550

1.88

8.41

1.5

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

492

3730

1.34

8.40

7.1

6.7

24.54

24.45

mmol/l

0.20

466

3527

(3016330) Potassium [Moles/time] in 24 hour Urine

101

3.18

8.33

1.1

1.3

—

97.62

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

797

6446

1.26

8.31

3.8

3.9

20.73

28.98

ug/l

0.27

618

5034

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

110

603

1.83

8.28

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

647

1.80

8.26

1.9

2.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

381

2.06

8.23

1.4

1.2

227.56

273.69

u/l

0.35

352

(3034770) Mitochondria Ab [Titer] in Serum

309

2180

1.43

8.19

1.3

891.00

1044.21

titre

—

(3023410) Appearance of Cerebral spinal fluid

147

880

1.68

8.17

1.4

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

138

814

1.71

8.10

6.4

7.1

10.66

11.36

mg/l

0.90

132

760

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

466

1.94

8.08

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

109

601

1.82

8.07

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

143

854

1.68

8.03

2.1

2.6

1.38

1.24

e9/l

1.08

124

742

(3003181) Sodium [Moles/volume] in Urine

174

1093

1.60

8.01

1.9

1.5

57.95

64.04

mmol/l

1.24

142

879

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

327

2.12

7.90

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

269

2.24

7.88

4.0

4.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

381

2.03

7.87

1.6

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

235

1588

1.49

7.80

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.05

7.79

2.3

1.4

45.38

42.73

umol/l

0.12

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

152

931

1.64

7.76

1.7

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

163

1018

1.61

7.70

1.1

1.46

1.49

g/l

0.47

156

915

(3002523) Influenza virus A Ag [Presence] in Specimen

234

1589

1.48

7.60

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

129

2.80

7.56

1.1

0.62

0.70

umol/24h

0.58

(40760888) Immunoglobulin light chains.free panel - Serum

198

1300

1.53

7.55

3.0

3.3

—

(3019150) Specific gravity of Urine by Refractometry

1879

16622

1.16

7.53

4.3

3.7

1.02

kg/l

0.26

272

2483

(3017446) Testosterone [Moles/volume] in Serum or Plasma

582

4587

1.29

7.52

2.3

2.1

10.24

11.45

nmol/l

2.88

510

4104

(3047181) Lactate [Moles/volume] in Blood

289

2056

1.42

7.35

5.3

5.8

1.35

1.26

mmol/l

0.87

261

1797

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

607

1.77

7.26

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

214

1443

1.49

7.21

2.3

2.1

0.97

0.80

nmol/l

1.39

171

1230

(3003694) ABO and Rh group [Type] in Blood

2708

24646

1.14

7.20

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

275

2.15

7.09

1.3

1.2

0.14

0.24

g/l

—

(3006653) Thiamine [Moles/volume] in Blood

362

2.00

7.08

1.4

1.3

139.29

132.68

nmol/l

0.63

362

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

108

620

1.75

7.05

1.1

8.66

9.72

iu/ml

0.11

151

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

152

956

1.60

7.02

1.2

1.1

1.71

2.33

iu/ml

—

(3029075) Extractable nuclear Ab panel - Serum

244

2.22

7.01

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

303

2196

1.39

6.95

3.2

3.5

985.10

2554.42

u/ml

0.55

261

1871

(3037121) Protein [Mass/volume] in Urine

338

2497

1.37

6.90

3.5

3.3

0.28

0.36

g/l

0.89

163

1095

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

109

632

1.73

6.88

1.3

1.74

1.96

mmol/l

3.00

102

592

(3018405) Lactate [Moles/volume] in Arterial blood

287

2066

1.40

6.85

4.5

3.7

1.40

1.37

mmol/l

0.21

281

2028

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1003

8480

1.20

6.84

4.3

4.0

31.91

32.43

0.84

764

6012

(3010838) Calcium [Moles/time] in 24 hour Urine

195

1305

1.50

6.84

1.7

2.0

4.86

5.15

mmol/24h

0.66

170

1165

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

210

1427

1.48

6.84

1.6

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

487

1.84

6.82

1.5

1.4

70.78

76.13

umol/l

1.43

487

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

345

2562

1.36

6.82

1.1

4.32

6.09

u/ml

0.60

351

(3038177) Helicobacter pylori Ab [Presence] in Serum

214

1461

1.48

6.81

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

204

1380

1.49

6.80

1.1

4.31

2.98

u/ml

0.52

686

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

336

2.00

6.66

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

343

1.99

6.66

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

248

1752

1.43

6.60

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

122

743

1.65

6.45

3.7

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

217

1507

1.45

6.35

4.6

4.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

133

833

1.61

6.30

2.2

2.1

23.43

24.61

mg/l

0.08

215

(21494890) Protein electrophoresis panel - 24 hour Urine

552

1.75

6.28

2.0

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

191

1299

1.48

6.23

1.1

55.17

8193.80

iu/ml

0.64

330

(3024666) Lithium [Moles/volume] in Serum or Plasma

569

1.73

6.20

11.9

11.3

0.58

0.60

mmol/l

0.61

519

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

150

2.47

6.16

1.4

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

305

2.01

6.15

1.4

94.80

158.07

nmol/24h

0.60

305

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

143

920

1.56

6.06

2.5

2.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

183

1247

1.48

5.94

1.3

—

(3020891) Body temperature

320

2403

1.34

5.93

5.5

4.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

462

1.78

5.78

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

131

836

1.57

5.77

1.8

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

131

836

1.57

5.77

1.8

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

306

1.97

5.75

2.0

2.1

8.48

9.70

mg/l

0.86

257

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

515

1.74

5.73

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

335

1.92

5.69

1.5

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

181

2.27

5.69

1.5

1.3

114.06

113.84

nmol/l

0.00

131

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

661

1.64

5.65

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

336

1.91

5.65

1.5

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

182

2.26

5.62

1.1

—

205.00

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

564

1.69

5.59

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

520

1.72

5.55

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

125

799

1.57

5.49

1.6

53.44

55.16

0.17

504

(3042733) HLA Ab [Presence] in Serum

250

2.05

5.47

4.8

5.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

135

2.45

5.43

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

421

1.79

5.38

1.4

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

533

1.70

5.36

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

116

733

1.59

5.36

1.3

1.4

—

titre

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

163

2.27

5.19

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

163

2.27

5.19

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

163

2.27

5.19

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

163

2.27

5.19

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

153

1037

1.48

5.16

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

608

1.63

5.15

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

122

788

1.56

5.15

1.5

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

113

718

1.58

5.12

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

1113

1.46

5.10

2.4

2.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

102

633

1.62

5.10

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

467

1.72

5.05

1.1

0.84

8.42

nmol/l

1.29

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.56

5.04

1.6

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.40

5.02

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

110

699

1.58

4.99

1.6

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

330

1.85

4.96

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

330

1.85

4.96

1.2

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

106

669

1.59

4.96

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

116

751

1.55

4.87

1.2

1.1

32.51

38.66

mg/l

1.27

628

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

2.16

4.85

4.5

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

181

2.16

4.85

4.5

2.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

443

1.72

4.84

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

113

729

1.56

4.82

1.1

214.04

238.74

mg/l

0.89

638

(3025018) Bordetella pertussis Ab [Titer] in Serum

573

1.63

4.81

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

111

714

1.56

4.80

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

335

1.83

4.75

1.9

2.9

0.92

1.38

ug/l

1.37

315

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

115

748

1.54

4.74

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

309

1.85

4.63

1.1

1.2

89.38

91.16

0.13

137

(3045424) Erythrocytes [Presence] in Urine

180

1286

1.41

4.63

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

239

1.97

4.62

2.2

2.1

—

(3008295) Osmolality of Serum or Plasma

114

745

1.54

4.61

1.6

1.5

280.13

281.18

mosm/kgh2o

0.18

580

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

611

1.59

4.60

1.1

1.0

284.92

291.84

mg/l

0.45

553

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1140

10068

1.15

4.56

1.9

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

429

1.71

4.54

1.5

1.4

34.25

19.44

u/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

297

1.86

4.53

2.5

2.1

12.10

122.66

ug/min

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

145

1002

1.45

4.49

1.6

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

277

1.88

4.47

1.3

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

117

2.40

4.46

1.2

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1415

12703

1.13

4.43

1.7

—

(4035726) Immunohistochemistry procedure

728

6226

1.18

4.41

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

162

2.16

4.41

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

189

2.07

4.38

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

177

1275

1.40

4.37

1.9

1.8

176.89

186.89

pmol/l

0.51

166

1206

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

255

1946

1.32

4.34

1.7

38.08

42.03

nmol/l

1.85

249

1894

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

316

1.81

4.34

1.1

91.85

91.93

0.01

137

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

338

1.78

4.33

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

825

9490

0.86

4.29

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

340

1.77

4.26

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

103

672

1.54

4.23

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

626

1.56

4.19

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

595

1.57

4.17

1.5

1.6

28.97

34.27

0.69

364

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

447

3672

1.23

4.17

1.3

211.48

228.29

miu/ml

0.48

212

1785

(3051651) Icteric interference index of Serum or Plasma

440

1.66

4.17

4.1

3.6

—

(40761535) Cells panel - Urine sediment

657

5599

1.19

4.16

4.1

3.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

644

1.54

4.13

2.0

2.7

530.58

517.25

e6/l

0.11

523

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

656

5596

1.19

4.11

3.1

2.4

68.96

71.60

ml/min/173m2

0.83

250

2146

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

122

835

1.47

4.01

1.3

1.4

8.11

7.73

mmol/l

0.53

117

816

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

310

1.78

4.00

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

184

1356

1.36

3.99

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1566

14236

1.12

3.97

4.7

4.6

2.24

2.59

ug/l

0.56

1401

12815

(3042631) Mycobacterium sp identified in Specimen

116

788

1.48

3.97

2.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

425

3493

1.23

3.96

1.6

1.7

4.92

4.00

mg/l

0.80

323

2521

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.60

3.96

2.9

3.0

1.23

1.39

mg/l

0.10

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

595

1.55

3.96

1.7

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

192

1428

1.35

3.93

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

628

1.53

3.93

2.0

2.8

0.22

0.21

e9/l

0.35

522

(43055514) Macroprolactin [Presence] in Serum or Plasma

298

1.78

3.89

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

313

1.76

3.88

2.1

2.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.45

3.87

1.4

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.50

3.87

1.5

1.6

0.52

2.20

mg/l

2.30

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

158

2.09

3.86

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

591

1.55

3.85

1.0

—

(40768446) Kidney Pathology biopsy report

307

1.76

3.83

1.7

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

929

8194

1.15

3.80

2.9

0.68

0.74

ug/l

1.28

614

5200

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

266

2082

1.29

3.80

6.1

5.8

1.50

1.38

mg/l

1.74

247

1948

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

200

1.95

3.80

1.1

71.29

68.91

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

180

2.00

3.77

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

266

1.81

3.71

1.1

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

1.11

2.02

mg/l

0.89

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

1.98

1.64

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

3.79

1.92

mg/l

0.43

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

0.28

1.30

mg/l

2.49

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

2.72

4.21

mg/l

0.73

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

1.89

3.40

mg/l

0.72

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

0.56

2.27

mg/l

2.54

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

0.78

2.90

mg/l

2.39

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.50

3.70

1.4

1.6

0.62

1.62

mg/l

0.99

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

2.13

3.69

7.1

6.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

252

1.83

3.69

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

1.79

3.68

1.0

1.1

—

(40768441) Liver Pathology biopsy report

550

1.55

3.68

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

6.67

3.67

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

425

1.63

3.67

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

110

2.28

3.60

1.2

1.3

109.40

68.90

ng/l

0.29

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

435

1.61

3.60

1.2

1.3

—

(40768795) Lymph node Pathology biopsy report

106

724

1.47

3.57

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

212

1.89

3.56

1.6

1.5

10.35

8.73

ug/l

0.86

212

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

516

1.56

3.53

1.6

1.5

—

(3004775) Volume in Urine collected for unspecified duration

469

1.58

3.52

2.3

743.33

614.80

0.77

328

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

200

1.90

3.47

2.4

2.2

12.91

16.32

umol/l

1.40

200

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

280

1.75

3.45

2.5

—

(3012441) Differential panel - Pleural fluid

504

1.55

3.42

1.6

1.5

—

(3016750) Collection duration of Urine

356

1.66

3.42

2.1

2.2

515.15

497.40

min

0.61

276

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

341

1.68

3.41

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

190

1446

1.32

3.39

2.4

2.3

145.10

93.24

ug/min

0.77

111

893

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

120

849

1.42

3.38

1.1

1.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

572

1.51

3.32

1.3

1.4

11.06

11.52

umol/l

0.32

547

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.92

3.29

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

322

1.68

3.29

1.6

2.5

249.44

249.27

e6/l

0.00

179

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.64

3.28

1.0

—

(3000012) Reticulocyte production index

115

816

1.41

3.20

2.6

2.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

675

1.46

3.20

1.4

1.3

4.13

5.53

umol/l

3.85

628

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

179

1364

1.32

3.19

1.8

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.41

3.13

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

532

1.51

3.12

1.6

1.4

22496.98

72903.01

e6/l

2.02

312

(3040151) Glucose [Moles/volume] in Capillary blood

109

771

1.42

3.10

4.6

4.9

7.93

7.09

mmol/l

0.29

635

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

201

1.84

3.10

1.1

94.60

80.91

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

159

1.95

3.08

1.4

1.6

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.00

3.08

1.1

1.2

0.21

0.20

g/l

—

(3024932) HLA-DR beta [Type]

268

1.72

3.07

1.0

1.1

—

(3012565) Volume of 24 hour Urine

368

1.61

3.05

2.2

2122.17

1992.32

0.37

339

(3017400) Magnesium [Moles/volume] in Urine

5.00

3.05

1.4

1.8

3.08

2.30

mmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

125

910

1.38

3.02

3.2

3.1

0.86

0.82

nmol/l

0.41

683

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

211

1.80

2.98

1.1

1.2

104.00

106.54

0.24

198

(3009871) Measles virus Ab [Titer] in Serum

301

1.66

2.97

1.9

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

228

1814

1.26

2.94

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

507

1.50

2.94

1.8

2.73

3.90

mg/l

4.93

489

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

287

1.68

2.93

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

413

4860

0.84

2.92

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

436

1.54

2.91

1.3

1.2

76.18

85.47

u/l

0.51

388

(3044927) Protein electrophoresis panel - Urine

566

1.47

2.89

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

397

1.57

2.89

1.5

1.7

2.05

4.39

nmol/l

1.11

322

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

421

1.55

2.88

1.3

1.2

18.14

20.59

u/l

0.25

367

(3004451) EKG impression Narrative

281

1.68

2.88

1.4

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

542

4699

1.16

2.87

2.9

3.1

34.58

45.64

u/ml

1.42

524

4546

(3039000) Anion gap in Blood

182

1413

1.29

2.87

6.3

6.9

11.27

11.25

mmol/l

0.03

164

1252

(3009214) Lutropin [Units/volume] in Serum or Plasma

361

3026

1.20

2.86

1.5

1.4

10.48

9.96

u/l

0.28

291

2452

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

462

1.52

2.86

2.0

1.7

—

(3018572) Chloride [Moles/volume] in Blood

182

1414

1.29

2.85

6.3

6.9

105.42

105.37

mmol/l

0.05

164

1253

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

259

1.70

2.85

3.3

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

207

1.79

2.85

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.29

2.83

8.7

11.9

5.42

5.55

mmol/l

0.08

(3024471) HLA-A [Type]

275

1.68

2.82

1.0

—

(3019977) pH of Arterial blood

330

1.61

2.79

4.8

2.8

7.42

0.30

114

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.92

2.77

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.26

2.76

1.6

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.31

2.74

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.20

2.73

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

146

1.92

2.69

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

357

1.57

2.68

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

454

1.50

2.65

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

250

1.68

2.64

1.8

1.7

319.60

115.59

au/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

597

1.43

2.58

1.6

1.4

1434.84

2374.60

e6/l

1.77

437

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

178

1.80

2.54

1.2

288.45

288.56

pmol/l

0.00

128

(3020491) Glucose [Moles/volume] in Blood

599

1.42

2.54

1.6

1.9

6.64

6.23

mmol/l

0.63

445

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

451

1.49

2.53

1.1

2.63

15.30

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

209

1.73

2.49

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1831

17146

1.08

2.49

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.32

2.48

1.1

—

(3024263) Appearance of Synovial fluid

349

1.55

2.47

1.2

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

102

2.06

2.46

1.3

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

463

1.47

2.44

1.3

1.4

122.64

182.33

pmol/l

1.99

463

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

256

1.64

2.44

2.4

2.7

28.03

27.88

umol/l

0.03

185

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.55

2.44

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

181

1.77

2.42

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

124

1.94

2.39

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

160

1.81

2.38

1.6

3.7

1.16

1.19

mmol/l

1.79

150

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.35

2.38

1.1

1.95

1.63

umol/24h

0.66

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

183

1.75

2.34

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

183

1.75

2.34

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

183

1.75

2.34

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

306

1.57

2.34

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

225

2735

0.82

2.33

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

284

1.59

2.30

4.1

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

261

1.61

2.28

1.5

2.0

—

(3028433) Virus identified in Specimen by Culture

261

1.61

2.28

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

261

1.61

2.28

1.5

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

2.94

2.27

1.0

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

521

1.42

2.26

1.1

1.04

1.06

u/l

0.16

227

(3002619) Bacteria identified in Specimen by Culture

156

1.80

2.24

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

171

1.76

2.23

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.13

2.18

1.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.3

1.0

18.94

21.05

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.3

1.0

37.15

36.85

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

3.34

2.18

1.0

7.44

8.20

—

(21494434) Karyotype in Bone marrow

552

1.40

2.14

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

266

1.58

2.13

1.6

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

157

1253

1.26

2.08

2.7

3.4

337.56

580.32

u/ml

0.44

141

1144

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

317

3694

0.85

2.08

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

522

1.40

2.07

1.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

439

1.44

2.06

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

146

1.78

2.05

2.3

2.4

1.57

1.61

mmol/l

0.03

108

(3034891) Synovial lining cells/100 cells in Synovial fluid

325

1.51

2.05

1.6

1.5

8.40

3.10

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.00

2.04

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

678

1.35

2.02

3.3

2.4

1.14

1.46

g/24h

0.71

346

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

164

1322

1.24

2.01

3.8

3.7

31.94

28.61

u/ml

0.14

155

1282

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

503

1.39

1.95

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.98

1.94

2.6

2.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

753

1.32

1.93

1.2

53.10

66.33

u/l

1.73

689

(3007463) Buprenorphine [Presence] in Urine

2.45

1.92

9.4

5.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

652

1.34

1.88

1.6

1.5

33.92

33.29

g/l

0.18

591

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.18

1.88

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

121

1.82

1.87

2.4

3.0

112.68

18.96

mg/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.65

1.86

1.2

2.8

—

(3015183) Erythrocyte sedimentation rate

491

1.39

1.86

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

568

1.36

1.85

1.2

1.1

1.08

1.05

ratio

0.63

203

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

137

1.75

1.82

1.1

1.2

0.47

97.71

mg/l

1.21

(36303858) Crystals [Presence] in Urine

4.17

1.82

1.4

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

318

1.48

1.82

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1213

11319

1.08

1.82

3.9

4.0

22.24

21.61

0.60

521

5163

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.57

1.80

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.79

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

345

1.45

1.77

2.7

2.9

160.57

143.52

au/ml

—

(3045788) Cell count panel - Pleural fluid

472

1.38

1.74

1.7

1.5

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.85

1.71

1.2

1.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.13

1.71

1.0

1.2

—

2.02

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

611

1.33

1.71

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

543

1.35

1.69

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

673

1.31

1.69

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

164

1.65

1.67

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.16

1.66

1.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

119

1.77

1.65

2.0

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

1.89

1.64

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.44

1.64

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

127

1.73

1.63

1.5

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.57

1.61

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.38

1.61

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

463

1.36

1.59

1.2

1.1

1466.84

1481.81

miu/ml

0.04

463

(3014891) Appearance of Pleural fluid

2.06

1.59

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

215

1.54

1.56

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

279

3199

0.87

1.56

1.8

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

114

1.76

1.56

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

1.55

3.6

3.4

—

(3017704) Immunofixation for Urine

305

1.44

1.55

1.8

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

240

1.50

1.54

3.3

2.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

100

1.80

1.52

4.5

5.2

31.08

41.61

ug/min

0.48

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.59

1.51

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

138

1.67

1.51

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

233

1.50

1.51

2.1

11.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

485

1.34

1.51

1.5

1.6

—

(3016038) Potassium [Moles/volume] in Urine

434

1.36

1.50

2.4

1.4

35.67

34.43

mmol/l

0.13

384

(3006462) Nitrate [Presence] in Urine

383

1.39

1.50

2.6

2.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

218

1.52

1.48

1.2

1.1

50.27

53.20

u/ml

0.11

210

(40762365) Oxygen content in Arterial blood by calculation

109

1.74

1.46

3.6

2.5

15.25

14.74

ml/dl

0.26

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.13

1.44

3.8

7.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.73

1.43

1.2

2.4

4.23

4.48

mmol/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

430

1.35

1.42

2.0

2.5

44.76

42.78

0.41

243

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

303

1.42

1.41

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.82

1.41

1.6

1.9

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

372

1.37

1.38

2.2

1.6

3128125.20

2002488.15

iu/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

308

3471

0.88

1.36

1.5

1.6

—

(3027874) Urate [Moles/volume] in Urine

2.94

1.36

1.0

2.44

1.64

mmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

231

1.47

1.36

1.9

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

151

1.59

1.34

1.6

2.4

—

(3020393) Adenovirus Ag [Presence] in Stool

144

1.60

1.31

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

144

1.60

1.31

1.7

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

309

1.39

1.29

2.5

6.2

80.42

67.13

mg/l

0.58

231

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

326

1.38

1.29

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

137

1.61

1.29

1.4

1.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.78

1.28

2.6

6.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

352

1.37

1.28

3.5

3.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

177

1.53

1.28

1.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.94

1.27

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.29

1.26

7.8

7.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

336

1.37

1.26

1.3

12.80

12.01

u/l

0.14

311

(3010144) Erythrocytes [#/volume] in Synovial fluid

589

1.28

1.26

1.3

1.4

80876.33

75287.89

e6/l

0.04

409

(3035933) Granulocytes/100 leukocytes in Blood

311

1.38

1.25

1.5

—

(40768793) Breast Pathology biopsy report

224

1956

1.15

1.25

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.22

1.24

3.8

2.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.86

1.23

1.2

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.97

1.22

4.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

116

1.64

1.21

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

1.16

1.7

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

210

1837

1.15

1.16

1.6

1.5

0.49

0.44

nmol/l

0.15

153

1467

(40762814) Titanium [Mass/volume] in Blood

1.69

1.13

2.6

2.3

2.80

4.36

ug/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

216

1.44

1.13

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

448

1.30

1.13

1.8

1.6

3.45

6.10

u/l

2.51

376

(3047189) Immunofixation for 24 hour Urine

258

1.40

1.13

2.5

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

175

1.49

1.12

1.1

1.2

38.26

38.73

g/l

0.05

(40757494) Bilirubin.total [Moles/volume] in Blood

353

1.33

1.11

3.0

2.4

19.05

72.56

umol/l

—

(3020650) Glucose [Presence] in Urine

242

1.41

1.11

1.5

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

788

8395

0.93

1.11

7.6

5.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

691

1.23

1.10

1.3

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

372

1.32

1.08

25.7

27.8

150.52

119.34

ug/l

1.69

314

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

1.08

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

112

1.61

1.08

1.5

1.2

—

(3014271) Vancomycin [Susceptibility]

269

1.38

1.08

2.9

2.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.65

1.06

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.06

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.12

1.05

9.4

4.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.12

1.05

13.1

9.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

375

1.31

1.04

1.2

1.7

1.19

1.30

nmol/l

0.32

296

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

521

0.75

1.03

1.3

1.51

1.57

g/l

0.68

521

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.63

1.03

1.4

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

132

1129

1.17

1.02

1.2

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

139

1.51

0.99

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

214

1.40

0.99

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

115

976

1.18

0.98

1.6

1.2

47.36

34.70

u/l

0.28

105

840

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

413

0.73

0.98

1.4

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.85

0.96

5.2

4.8

—

(3025130) Human papilloma virus identified in Specimen

171

1500

1.14

0.96

1.7

—

(3017569) Oxygen content in Arterial blood

267

1.35

0.95

3.3

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

417

1.27

0.94

1.0

94.87

91.17

0.32

330

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

373

1.29

0.93

3.5

8.43

8.24

mg/l

0.09

297

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.22

0.93

1.3

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

2.22

0.93

1.7

1.2

—

(3048879) Bone marrow aspiration report

158

1.46

0.93

1.3

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

150

1.47

0.92

9.6

7.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

835

1.19

0.92

3.9

4.7

39.89

82.61

u/ml

1.53

263

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

788

8333

0.94

0.92

1.7

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.63

0.90

3.0

3.7

—

(4146454) Self-monitoring of blood glucose

646

1.21

0.89

2.8

—

(3006270) Folate [Moles/volume] in Blood

592

1.22

0.88

1.2

1.1

354.48

387.65

nmol/l

0.78

530

(37021550) Renin [Units/volume] in Plasma --upright

169

1.42

0.87

1.2

1.3

120.18

107.60

mu/l

0.04

133

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

378

1.27

0.86

1.6

1.91

3.20

u/field

0.95

266

(3052592) Norovirus Ag [Presence] in Stool

120

1.50

0.85

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

309

1.30

0.83

1.2

1.1

71.00

346.43

ng/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

159

1796

0.88

0.83

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

111

0.54

0.83

8.5

6.1

81.83

71.32

—

(3041806) Other cells [#/volume] in Blood by Manual count

534

0.79

0.82

1.7

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

214

1.36

0.82

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

197

1.37

0.81

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

165

1.39

0.77

9.2

6.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

769

1.17

0.76

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.76

0.0

8.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

576

1.20

0.76

1.5

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.64

0.75

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.08

0.74

1.6

1.2

258.80

330.50

nmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

523

1.21

0.74

1.9

2.0

2.09

1.93

u/field

0.08

225

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

539

5716

0.94

0.73

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

108

1.48

0.73

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

190

1714

1.11

0.73

1.4

23.05

24.55

u/l

0.26

161

1418

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

335

1.25

0.71

1.2

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

335

1.25

0.71

1.2

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

362

3369

1.08

0.71

1.9

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

291

1.27

0.70

4.6

3.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

101

1.49

0.70

5.9

7.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.71

0.70

1.0

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

235

2150

1.10

0.69

1.3

1.4

87.39

129.13

pmol/l

1.74

228

2096

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

118

1.44

0.69

1.2

71.41

404.24

ug/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

0.68

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.59

0.68

2.0

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

110

1.46

0.68

2.8

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

249

1.29

0.67

2.9

3.4

—

(3007733) Chloride [Moles/volume] in Urine

1.79

0.66

4.6

1.4

105.20

75.91

mmol/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

188

1.33

0.66

2.1

1.6

0.17

0.25

nmol/l

0.68

133

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.54

0.65

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

1.72

0.64

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.52

0.62

2.1

2.6

3.42

3.30

mg/l

0.04

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.60

0.0

1.2

—

4640.17

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

426

1.20

0.59

1.2

1.3

62.20

68.70

—

(40757373) Influenza virus identified in Isolate

140

1.36

0.58

1.9

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

689

7195

0.95

0.57

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

106

1.42

0.57

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.48

0.57

11.0

5.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

1.37

0.55

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.45

0.55

1.8

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

975

0.88

0.54

1.4

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.50

0.54

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

178

1.29

0.52

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.50

0.51

2.2

4.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.46

0.50

1.2

1.0

7.29

8.42

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

199

1.26

0.47

1.8

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.49

0.47

7.1

1.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.41

0.46

1.0

1.1

—

(3034426) Prothrombin time (PT)

301

1.20

0.45

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

112

1.34

0.44

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.40

0.44

9.6

7.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

166

1.27

0.43

2.2

1.6

0.40

0.42

ug/l

0.06

107

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

452

1.15

0.42

2.0

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

284

0.81

0.42

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.47

0.40

1.8

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.47

0.40

1.0

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.47

0.40

1.0

1.1

0.02

0.03

mg/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

561

5404

1.04

0.40

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.34

0.39

1.2

1.1

—

(3032641) Amino acids panel - Urine

0.00

0.39

0.0

1.4

—

(40765096) Chromosome analysis panel by Banding

196

1.23

0.39

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.39

0.38

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.33

0.37

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.29

0.36

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.36

0.36

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.43

0.35

1.3

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

123

0.73

0.35

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

350

0.86

0.33

6.7

5.7

120.44

9534.01

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

182

1.21

0.33

2.1

1.5

—

(3006598) pH of Arterial cord blood

187

0.80

0.32

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

306

1.14

0.29

1.4

1.5

14.67

14.61

pmol/l

0.02

261

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

103

1.26

0.28

2.4

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

391

3782

1.04

0.27

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.26

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

391

3785

1.03

0.26

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.30

0.26

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.67

0.25

2.8

2.3

1.80

0.64

u/field

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

132

1.21

0.25

1.2

1.3

—

(3001556) Androgen free Index in Serum or Plasma

132

1.21

0.25

1.3

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

388

3760

1.03

0.25

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

417

4047

1.03

0.24

1.4

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

1.18

0.24

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

315

3043

1.04

0.24

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

389

3773

1.03

0.24

1.4

—

(3005033) Fetal Nuchal fold Thickness US

313

3029

1.03

0.23

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.24

0.22

1.3

46.00

57.23

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

506

1.09

0.22

5.4

6.7

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.16

0.21

1.2

1.5

42.92

19.55

nmol/l

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.16

0.21

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.8

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.20

0.0

1.0

—

0.01

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.25

0.20

2.2

2.9

—

0.00

—

(40758292) HTLV I+II Ab panel - Serum

136

1.18

0.20

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.22

0.20

1.7

2.8

—

(3051101) Glucose [Moles/volume] in Cord blood

1.21

0.19

6.3

—

(40768800) Prostate Pathology biopsy report

860

1.06

0.19

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.19

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.21

0.18

1.0

1.1

9.71

14.28

u/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

100

1.20

0.18

1.0

—

(4281824) Cell count and differential, peritoneal fluid

843

1.06

0.18

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.15

0.17

1.0

1.1

13.90

10.32

mg/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

137

1317

1.04

0.16

1.3

1.4

7.16

6.95

mmol/l

0.36

122

1183

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

360

1.08

0.16

2.3

2.4

48.58

50.84

umol/l

0.16

317

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.11

0.16

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.21

0.15

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

319

3116

1.02

0.15

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

182

0.88

0.15

1.5

49.45

61.65

0.51

150

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

121

1.16

0.15

1.0

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

313

1.09

0.15

2.6

2.4

158.74

151.48

nmol/l

0.15

269

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

1.13

0.13

1.6

1.4

15.38

12.66

g/l

0.53

110

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

191

0.89

0.13

2.6

2.0

14239.17

15883.06

e6/l

0.04

108

(3045462) Protein/Creatinine [Ratio] in Urine

138

0.87

0.13

4.9

5.2

3648.63

70.35

g/mol

0.46

125

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

0.87

0.13

1.7

2.7

—

(3025577) Chromium [Mass/volume] in Blood

345

1.07

0.12

2.1

1.35

2.59

ug/l

2.91

293

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

168

0.89

0.11

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

386

1.06

0.11

1.0

726.12

735.50

ng/l

0.06

262

(3033799) Differential panel - Peritoneal fluid

182

1.10

0.11

2.3

2.2

—

(3044007) Cell count panel - Peritoneal fluid

173

1.10

0.10

2.2

2.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.14

0.10

21.2

6.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.14

0.10

1.4

1.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.09

0.09

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

184

1880

0.98

0.09

1.3

3.56

3.83

ug/l

0.15

168

1712

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.06

0.09

1.6

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.15

0.09

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

389

1.05

0.09

1.0

47.64

44.80

ng/l

0.15

266

(40765089) Chromosome analysis panel - Blood by G-banded

370

0.95

0.09

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

614

0.96

0.09

2.7

3.0

46.69

58.05

mg/l

0.23

453

(3051387) C reactive protein [Mass/volume] in Capillary blood

152

1554

0.98

0.08

4.1

3.3

21.67

26.19

mg/l

0.97

941

(3022475) Manganese [Moles/volume] in Blood

1.03

0.08

1.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.82

0.08

1.2

1.4

66.40

73.60

—

(3035880) pH of Pleural fluid

273

1.06

0.08

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

618

1.04

0.08

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

176

1.08

0.07

1.2

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

176

1.08

0.07

2.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

104

0.87

0.06

1.2

3.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

384

1.04

0.06

1.1

1.0

319.12

332.75

ng/l

0.12

268

(3034092) Cytoplasmic Ig cells/100 cells in Blood

109

1.10

0.06

7.9

6.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

162

0.93

0.06

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

171

1728

0.99

0.03

1.8

—

(1761868) Lipid panel - Serum or Plasma

2921

29163

1.00

0.03

2.8

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

354

3520

1.01

0.03

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

152

1.05

0.02

2.4

4.3

262.00

68.75

u/l

0.45

147

(3039443) Prostate specific Ag panel - Serum or Plasma

939

1.01

0.02

1.7

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.08

0.02

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

368

0.98

0.01

1.1

99.45

76.29

u/l

0.87

337

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

213

1.03

0.01

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.06

0.01

7.5

2.8

—

(3022689) Creatine [Moles/volume] in Urine

206

0.97

0.00

1.7

1.5

—

(4034850) Laboratory test

237

2363

1.00

0.00

9.8

8.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

187

1.02

0.00

2.9

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

187

1.02

0.00

5.8

6.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

214

0.98

0.00

2.4

2.3

1560.94

952.37

e6/l

0.29

156

(3021162) Amylase [Enzymatic activity/volume] in Specimen

125

1.04

0.00

4.1

3.1

451.31

3480.06

u/l

1.59

118

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

185

1.03

0.00

1.2

1.3

55.50

38.41

—

120

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

365

0.99

0.00

1.1

26.66

19.06

u/l

0.39

334

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

392

0.99

0.00

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

249

1.00

0.00

2.1

2.4

122.16

123.29

ng/l

0.01

144

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.90

0.00

1.0

171.17

163.58

g/l

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.2

—

15.00

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.67

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

0.91

-0.00

1.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED – Adverse effects, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adverse effects, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Adverse effects, not elsewhere classified (ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints